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Abstract 
Umbilical cord blood (UCB) stem cells form commonly banked types of human 
tissue. Confusion remains about sources of stem cells and their use. Birth is a once in a 
lifetime opportunity with 74 million births per year in the world and four million occur in 
the United States. Cord blood contains hematopoietic stem cells and pluripotent 
mesenchymal cells (Moise, 2005). There is a surge of interest in the clinical use and 
research investigation of umbilical cord blood for transplantation and regenerative 
medicine. Clinicians need increased awareness and education of options for private 
versus public donation and banking of cord blood at birth to present to pregnant patients. 
The aims of this research were to describe decision-making readiness and 
communication with mothers and their partners during her pregnancy using the 
Transtheoretical Model (Prochaska, J.O. and DiClemente, C.C, 1982). Describe the 
relationship between age, pregnant women's level of parity, gestational age, highest level 
of education, marital status, race, religion, economic status, and plan of payment for 
prenatal care to their sources of knowledge, their beliefs and knowledge regarding cord 
blood transplantation. Perceptions of pregnant women's cord blood use and their 
understanding of the difference between public and private cord blood storage banks and 
use. The partner's perceptions of cord blood use and their understanding of the difference 
between public and private cord blood storage banks and use. 
The voluntary sample consisted of 30 participants of convenience from two 
obstetrical clinics from a local clinic. The design was a quantitative method staging an 
algorithm for Cord Blood Donation using a Decision of Readiness Scale along with 
notification of significant other. The Cord Blood Survey measured sources of knowledge, 
beliefs, and knowledge of cord blood transplantation. The Statistical Package for the 
Social Sciences (SPWS 18.0) was used to perform an analysis of data. Descriptive 
statistics were used to summarize the demographic variables and to identify central 
tendency, variability and percentages of key variables. One-way ANOVA and /-test were 
computed on the quantitative questions. Qualitative measures from randomly selected 
post interviews of 1/3 of the sample were completed. 
The barriers to understanding what umbilical cord blood donation options and 
how pregnant women make decisions regarding umbilical cord blood donations are 
explored. The implications for nursing research are: overcoming the barriers to 
understanding the difference between private and public banking and the ramifications of 
each option; add to nursing knowledge by understanding when and how women make 
decisions about umbilical cord blood donation; and future studies could investigate 
ethical implications of umbilical cord blood donation and best nursing practice guidelines 
for approaching pregnant women and their partners on umbilical cord blood donation 
options. 
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Stem cells from umbilical cord blood form one of the most commonly banked 
types of human tissue. Birth is a time when stem cell collection is an option through 
umbilical cord blood collection. Despite over 74 million births per year in the world and 
of those four million of which occur in the United States (World Watch Institute, 2006, 
p.75), many people remain unaware of human umbilical cord blood collection (Cryo-cell, 
2006). Who would have known thirty-five years ago, when this researcher a new 
graduate nurse routinely collecting cord blood at a birth to determine the baby's blood 
type, some day one would be collecting it for stem cell research on a baby. To make the 
decision to bank cord blood for stem cell collection is a life experience one can only 
capture at a timely moment Birth! 
The debate over embryonic stem cell research continues in the news headlines 
over the last two decades. Despite this, many people remain unaware that the human 
umbilical cord blood and other noncontroversial stem cell sources, such as the placenta, 
are routinely used in medical treatments. Tremendous confusion and lack of 
understanding about the different sources of stem cells and their use affects members of 
the government, public, and medical community. It is important to note that embryonic 
1 
2 
tissue is not the only source of stem cells and is not part of this study (see Appendix A: 
Sources of Stem Cells). Until 1988 (Smith & Thomson, 2000) and April, 2006 (Cryo-
cell, 2006), blood that remained in the umbilical cord and placenta, respectfully, after 
delivery used to be routinely discarded. Now several studies have confirmed with similar 
results this blood is known to contain hematopoietic stem cells and pluripotent 
mesenchymal cells (Moise, 2005); undifferentiated cells that can develop into virtually 
any type of blood cell in the human body; and provides a better alternative to bone 
marrow transplantation to treat an expanding list of malignant, benign, and inherited 
disorders (Perlow, 2002) (see Appendix B showing a list of diseases potentially treatable 
with stem cells from umbilical cord blood). As a result, a surge of interest in the clinical 
use and research investigation of umbilical and placental stem cells in transplantation and 
regenerative medicine has evolved in the science of stem cell research. 
Background of the Problem 
Until President George W. Bush signed a bill December 20,2005, the Federal 
Drug Administration (FDA) had no control over some of the standardizations for 
collection and processing of cord blood in public banks (Institute of Medicine, 2005 & 
2006; Perlow, 2006). The debate regarding private banking of autologous blood for 
"biological insurance" versus public banking for access by the general public continues 
today. Lack of knowledge and expense remain as barriers to umbilical cord blood 
collection and placenta stem cell collection. Opportunities to educate patients and 
obstetrical providers in these areas need to be pursued if one is to make a true informed 
decision (Perlow, 2002). Obstetrical providers need to support acquisition but many do 
not even have a basic understanding of newborn stem cell research derived from post-
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delivery stem cell banking. Patients are poorly informed about options in umbilical blood 
banking, especially in ethnic minorities (Perlow, 2006), and unless a parent, relative, or 
friend opens the internet specifically to download umbilical cord blood collection or 
placental stem cell collection and obtains the information somewhat easily, this process 
of collection is virtually unknown to the public. Many people, including medical 
professionals, are eager to learn more about newborn stem cell (NBSC) banking, yet they 
are unaware of recent regenerative medicine research or the many diseases that are 
currently treatable with stem cells. Pregnant women, who not only decide the fate of their 
newborn's wardrobe colors, and ultimately the choice to collect stem cells, frequently 
look to their clinicians for guidance in evaluating their options to collect stem cells or not 
to collect stem cells and how to go about it! In addition, many health care professionals 
are unaware of the federal legislation to establish nationwide cord blood banks. They 
have never initiated a discussion with a patient about cord blood banking and are 
unprepared to answer an expectant mothers' question (Young, 2006). As more pregnant 
women become aware of the importance of cord blood stem cells, it is increasingly 
necessary for clinicians to be well informed. Considering the accessibility and availability 
of large quantities of newborn stem cells (NBSC), it seems likely that much of the future 
of stem cell therapy may depend heavily on newborn stem cells. 
Originally stored for the treatment of hematological disorders stem cells have now 
been found to be more versatile for potential use in the treatment of a broader range of 
disorders and diseases and may be particularly valuable in cell therapy and regenerative 
medicine (Gunning & Holm, 2006, p. 17; Waldby, 2006). The storage of umbilical cord 
cells has not been without controversy and there is rapidly growing private sector 
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involvement. Over the last two decades umbilical cord blood has proved an effective 
substitute for bone marrow in the treatment of blood disorders, and most nations in the 
developed world have public programs for the harvesting and storage of cord blood for 
allogenic transplantation (Garcia & Torrabadella, 2006; Waldby, 2006). Yet, a number of 
ethical issues continue to be debated involving questions of regulation and quality 
assurance, ownership and commercialization, patenting, and the financial constraints 
could make this unreachable for marginalized populations in the United States. The 
researcher will first present the historical background of related and unrelated cord blood 
to establish the legitimacy of the science, public versus private banking, regulation and 
quality assurance of banking and the worldwide influence cord blood banking has on 
regenerative medicine. 
Purpose of the Study 
The study researched and investigated issues surrounding knowledge by 
healthcare providers and patients' perceptions of cord blood collection or newborn stem 
cell collection (NBSC) and banking. From a philosophical perspective this appears to be 
a source of hegemony where the issue is dominated from a white male power base whose 
only voice seems to matter in the present situation. However, this researcher would like 
to take a postmodernist viewpoint and approach it with a critical/feminist theory where 
everyone has a place in the dialogue. Habermas a major contributor to critical theory and 
stressed: human beings in dialogue with each other are the foundation for emancipatory 
social thought and we all need to have a voice in this through the truths claimed and 
communication shared about the issues (Finlayson, 2005, page 59; J.M. Georges personal 
communication, September 7 & 14,2006). 
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This purpose of the study investigated pregnant women's knowledge of cord 
blood collection and what decision-making process they experience to donate cord blood 
at their birth. The research question: What characteristics during a woman's 
pregnancy are possibly related when making a decision for cord blood donation at 
birth? 
Specific aims for this inquiry are as follows: 
1) To describe the readiness of decision-making and communication to her significant 
other during a given time in a pregnant woman's gestational age. 
2) To describe pregnant women's age, weeks of pregnancy (gestational age), level of 
parity (number of pregnancies), marital status, race, religion, highest level of education, 
economic status and method of payment for prenatal care. 
3) To examine the relationships between women's age, weeks of pregnancy (gestational 
age), level of parity (number of pregnancies), marital status, race, religion, highest level 
of education, economic status and method of payment for prenatal care. 
4) To examine pregnant women's perceptions of cord blood use, difference between 
public and private cord blood storage banks and use. 
5) To examine pregnant women's partner's perceptions of cord blood use, difference 
between public and private cord blood storage banks and use. 
Conceptual Framework 
The transtheoretical model (TTM) of change provides an alternative way of 
grouping patients according to their stage of readiness to learn and adopt new beliefs and 
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by 
understanding the clients' readiness to change one can design intervention to increase the 
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chance of successful implementation (Haslam & Haslam, 2000). The dimensions 
described in the model, the stages, processes, context, and markers of change, are 
designed to assist in picturing and understanding the process of change (Prochaska & 
DiCIemente, 1984; DiClemente & Prochaska, 1998, pp.3-24; DiClemente, 2003). 
Transtheoretical Model (TTM) incorporates elements of various theories of therapy, 
learning, and behavior change, hence the term 'Transtheoretical'. The model, however, 
does not try to resolve all the conceptual issues and conflicts among the various theories 
incorporated in the model. It simple tries to identify and describe important elements of 
the process of intentional behavior change (DiClemente, 2007) (see Appendix C for 
figure of Stages of Change Model). 
Scope and Delimitations of the Study 
Umbilical cord cell transplantation has evolved over the last 15 years from being 
an experimental procedure to an accepted treatment for a number of hematological 
diseases and genetic disorders. Presently it is used, for example, in treatment of Acute 
Myelogenous Leukemia, Chronic Myelogenous Leukemia, Acute Lymphoblastic 
Leukemia, Chronic Lymphocytic Leukemia, Juvenile Myelomonocytic Leukemia, 
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myeloma (cancer of plasma cells) 
and Wiskott - Aldrich Syndrome to name a few (see Appendix B). During the evolution 
of banking cord blood as human tissue it has increased exponentially around the world. 
The proliferation of private cord cell banks has been particularly strong in the USA and 
Asia while, in Europe, where there are one or two old established private banks, the 
emphasis has been on public cord cell banking (Agarwal, 2006; Greenwood, 2006). But, 
whether in the private or public cord cell banking sector, there remains alternate quality 
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assurance standards that need addressing. This will become particularly important if cord 
blood stem cells are to play an important part in the cellulaf therapies of regenerative 
medicine in the future (Greenwood, 2006) (see Appendices D and E). As the utility of 
these cells increases countries may have to consider whether cord blood should be 
collected from all newborns. This will be a costly process if only obtained by the private 
banks and may be the promotion of public cord blood donation but with the 
acknowledgement that one has the right to private storage may prove a practical way 
forward. It is also clear within this frontier of science that new ethical questions will 
continue to arise. 
Outline of Proposal 
Following this introduction, a review of current relevant literature in the area was 
presented. The conceptual model was discussed as how it is related to this study by laying 
the framework for the area of inquiry. Operational definitions were reviewed. 
Explanation of the dissertation's importance to the advancement of knowledge, 
nursing science, and nursing practice were addressed. The methods to be used in this 
study were then described, including a detailed description of the research procedure and 
proposed data analysis plans. 
Chapter II 
Overview 
Just as the "interests and welfare of the human being prevail over the sole 
interests of science and society so does society and the culture of healthcare send us into 
new technology", (Gunning & Holm, 2006, p. 7, Chap. 2). This section briefly describes 
the milestones reached in umbilical cord blood transplantation. The researcher will first 
present the historical background of related and unrelated cord blood to establish the 
legitimacy of the science, public versus private banking, then expand on the regulation 
and quality assurance of banking and the worldwide influence cord blood banking has on 
regenerative medicine. 
Historical Background 
Stem cell research started in 1925 (Maximow, 1925, pp.47-113) and has been a 
very controversial subject when connected to embryonic stem cell research. However, 
umbilical cord blood and placental stem cells are not considered embryonic but are 
embryonic-like and are now classified currently under newborn stem cell research. The 
study of umbilical cord blood began in 1982, when discussions between Broxmeyer and 
Boyse led to laboratory experiments suggesting umbilical cord blood contained 
hematopoietic stem cells that might be suitable for transplantation (Broxmeyer, 1998, (a); 
8 
9 
Broxmeyer & Smith, 1998, (b).The concept of using umbilical cord blood as a source of 
stem cells was first proposed by Edward Boyse in 1983 (Wagner, 1993). 
Because of the need for quick access when patients were seeking a match for 
transplantation with their blood an organized blood banking system soon seemed to be 
the answer. Broxmeyer and Boyses' (Smith & Thomson, 2000) laboratory-based research 
led to establishing umbilical cord blood banking and was first successful at Indiana 
University to harvest cells from the siblings of children needing transplants. One of these 
units was used to perform the first related sibling transplant with umbilical cord blood in 
a 6 year-old boy with Fanconi anemia in 1988 in Paris, France (Gluckman et al., 1989). 
Gluckman further described this as a trans-Atlantic collaborative effort as the cell 
processing was done in the USA and hand carried to the patient in France. It was after 
this case that cord blood banks were established in the early 1990's first in New York in 
1993 and then in Europe through the London Cord Blood Bank, the first in the UK set up 
in 1996 (Waldby, 2005). Subsequently, over 35 cord blood banks have been established 
in 21 countries and today there are over 150,000 cord blood units worldwide both in the 
public and private sectors (Bone Marrow Donors Worldwide, 2003, Chap. 3; Agarwal, 
2006) 
One year later in 1989 Harris and colleagues performed the first umbilical cord 
blood transplant matched to a related sibling in Cincinnati (Gluckman, 1989; Smith & 
Thomson, 2000). Kurtzberg and colleagues at Duke University in Durham, NC, 
performed the first successful unrelated sibling umbilical cord blood transplant in the 
United States in 1993 (Kurtzberg, Graham, Olson, Stevens, & Rubenstein, 1994). The 
possibility to use unrelated donor cord blood grafts stimulated the need for a storage bank 
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of unrelated donor cord blood units. To address this need, Rubinstein and colleagues at 
the New York Blood Center created the fastpublic umbilical cord blood bank, designed 
to test the safety and efficacy of collecting, testing, cryopreserving, and dispersing 
umbilical cord blood collected from unrelated donors to transplant centers (Rubinstein, 
Rosenfeld, Adamson, & Stevens, 1993; Rubinstein, Taylor & Scaradavou, 1994; 
Rubinstein, Carrier, & Scaradavou, 1998). 
The first private cord blood bank, Biocyte Corporation, was set up in Connecticut 
in 1993 (Holden, 1993) and now private cord blood banks operate throughout the USA, 
Europe and Asia. Wagner published the first series of cord blood recipients in 1995 
representing the Placental and Umbilical Cord Blood Registry (Wagner, Kernan, & 
Steinbach, 1995). They reported the transplant results for 44 related, sibling cord blood 
grafts. This was followed in 1996 by Duke University's center reporting 25 unrelated 
donor cord blood transplants (Kurtzberg, Laughlin, & Graham, 1996) and in 1997 by 
Gluckman's report of the European experience with 78 related and 65 unrelated donor 
cord blood transplants (Gluckman, Rocha, & Boyer-Chammard, 1997). In 1998 
Rubinstein reported the results of 562 unrelated donor cord blood transplants that were 
facilitated by the New York Blood Center's cord blood bank in New York City which is 
the largest series of cord blood transplants reported to date (Rubinstein, Rosenfeld, 
Adamson, & Stevens, 1993; Rubinstein, Taylor & Scaradavou, 1994; Rubinstein, Carrier, 
& Scaradavou, 1998). Recently, April 2006, Cryo-cell and Gen-cell were the first to 
initiate the collection of placentas for placental stem cell research (Cryo-cell, 2006). The 
reports provide important and encouraging results on cord blood obtained from related 
and unrelated donors establish a basic foundation for the science of stem cell research 
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and hope for parents who desire information on this issue. The replication of the science 
sets a firm bases on which to set a practice of use worldwide (see Appendix F: Historical 
Milestones of Umbilical Cord Blood Banking and Transplantation). 
What is Public Banking vs. Private Banking? 
> Information regarding umbilical cord blood (UCB) banking is surfacing at an 
accelerated rate in the past few years. The messages, with the predominate target towards 
vulnerable populations as pregnant women, women of childbearing age and women, 
encourage mothers-to-be to bank their child's umbilical cord blood. Because UCB stem 
cells must be collected at birth, women should decide what to do with their child's 
umbilical cord blood well in advance. To discard, donate for research, publicly store or 
privately store UCB stem cells—these are potential choices that have to be made. As 
anticipated, a growing number of Internet sites and magazines advertisements are 
cautioning women that storing a newborn's UCB is a once-in-a-lifetime opportunity and 
probably an investment that can save their child if it were to become necessary. When 
this researcher downloaded on Google "cord blood banking" in the Summer of 2008 
there were over one million seven hundred thousand entries compared to Winter 2006 
when there were approximately seven hundred thousand (Carr, I. personal computer 
search, February, 2006 to July 10,2008). Now that stem cells harvested from UCB have 
been successfully used for hemopoietic stem cell transplantation in unrelated adults 
(Laughlin et al., 2004; Rocha et al., 2004; Sanz,2004; Kharaboyan, Knoppers, Avard, & 
Nisker, 2007) they are actively being sought by families and researchers. Stem cells 
harvested from UCB have been used to substitute for bone marrow as a source of 
hemopoietic stem cells for transplants in the treatment of genetic disease, blood 
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malignancies, and immune deficiencies (Kharaboyan, Knoppers, Avard, & Nisker, 2007). 
The dedicated promise of private banking, coupled with pleas from public banks asking 
mothers to donate UCB for altruistic purposes, can become confusing for pregnant 
women as well as the general public. The empirical conclusion would be: Women who 
know more about UCB banking are more likely to make appropriate choices for both 
themselves and their families (Kharaboyan, Knoppers, Avard, & Nisker, 2007) and that 
would be by deciding to donate umbilical cord blood. This researcher wants to know: do 
they really do that and if they do, what is their understanding when they are making that 
decision? 
Banking is of two types i.e. public and private. A woman can donate cord blood 
for an unrelated recipient to public banks (unrelated allogeneic transplantation). Private 
(commercial) banks, on the other hand, offer expectant parents the option to store cord 
blood for possible future use by that same child (autologous transplantation) or familial 
use. Women and mothers-to-be need to have a balance of information presented to them 
about private and public cord blood banking so they will feel comfortable to make an 
informed decision. 
Before deciding to privately bank UCB, women should be advised of both the 
benefits and limitations of private banking. Considering one can guarantee easy access to 
their own stem cells for themselves or for a family member with an actual need of stem 
cell transplantation, it is equally important to inform mothers that presently it is highly 
unlikely for a family with no history of blood diseases to ever need the banked UCB 
(Fisk, Roberts, Markwald, & Mironov, 2005; Kharaboyan et al., 2007). This is in 
agreement with The American Academy of Pediatrics (American Academy of Pediatrics 
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[AAP], 1999 & 2007) who is against the private collection of cord blood as the need is 
minimal. One of the reasons would be the research shared where two estimates 
calculating the possible likelihood one would need the same blood given by the donor 
(autologous) to range from 1:2,700 (Moise, 2005 and 2006) and another from 1:1,000 to 
1:200,000 (Witte, 2005). This fact was recently addressed by Kingsbury (2008) in a 
popular public news journal in the health section of that resource through the following 
comment: 
"Cord blood transplants also require a less perfect match in unrelated people, 
opening up a broader spectrum of potential donors, and recipients' bodies are less likely 
to reject a transplant" (Kingsbury, 2008, pp. 2-3). 
The issue of private banking has generated controversy in recent years due to the 
aggressive marketing tactics of some private collection-and-banking facilities. Large 
numbers of organizations worldwide have started discouraging autologous or private 
banking. In addition to the American Academy of Pediatrics (AAP) and American 
College of Obstetrics and Gynecologist (ACOG), the Royal College of Obstetricians and 
Gynaecologists' Scientific Opinion condemned the practice of private cord blood 
blanking (Royal College of Obstetricians and Gynaeocologists, 2001, p. 2), and the 
French National Consultative Ethics Committee and European Group on Ethics in 
Science and New Technologies are discouraging its use (Agarwal, 2006;). Italy has 
completely banned autologous and private banking (Rendine et al., 2000) by law and it is 
forbidden by the Ministry of Health in China. Canada takes a similar view and has 
published guidelines (Canadian Institutes of Health Research [CIHR], 2005; Armson, 
2005). The Global Biopolitics Research Group out of Sydney, Australia has written a 
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working paper titled: Umbilical Cord Blood: from Social Gift to Venture Capital which is 
reflected by C. Waldby (2006): 
Private cord blood banking has been largely condemned by bioethical and 
medical professional bodies, on the grounds that the likelihood of any particular 
individual needing a cord blood transplant is very low, and that public, redistributive 
banking is a more efficient use of resources (p. 2). 
The advantages and limitations to public banking of UCB should be clear before 
making a decision. Public banking of UCB is to initiate use to a human resource for the 
greater good of all. Public banks collect units from patients of a wider ethnic diversity. 
Even though public banks are designed to improve donor matches for minorities, a recent 
study revealed that cord blood donation from minorities has remained low. An American 
Red Cross survey in 2001 showed that 64% of donors are white, 16% African American, 
and 12% Hispanic, 4% Asian, 1% Native American, and 3% other (Ballen, Hicks, & 
Dharan, 2002). In an effort to increase minority units, the IOM (Institute of Medicine) 
report advised that 100,000 new quality umbilical cord blood units could be collected in a 
national cord bank system (Institute of Medicine, 2005). For the marginalized patient, the 
cost of personalized cord blood collection and storage is prohibitive and will be 
addressed in detail in another section of the dissertation. When the studies keep 
introducing and replicating the science of cord blood transplants from unrelated donors 
coming from public banks which may succeed with one or two HLA mismatches (Moise, 
2005), as novel therapies in the treatment of cystic fibrosis (Sueblinvong, Suratt, & 
Weiss, 2007), transplantation for primary immunodeficiency (Gennery & Cant, 2008), 
indications and donor selections for allogeneic stem cell transplantation in children with 
15 
hematologic malignancies (Handgretinger, Kurtzberg, & Maarten Egeler, 2008), or issues 
to consider for successful vaccinations in children with hemopoietic stem cell 
transplantation (Patel, Chisholm, & Heath, 2008), one may start to agree that this is safe 
and ethically the right option for some families. Mothers may donate cord blood at the 
time of delivery at no charge and are given access to suitable matches if the need ever 
arises for immediate family members (Lui, 2006). 
Insufficient dumber of Hemopoietic Stem Cells in Umbilical Cord Blood 
The problem with insufficient number of precursor stem cells found in cord blood 
can explain why familial use is unlikely going to be an advantage. Kurtzberg (2005) 
conducted research showing that stem cells found in a unit of cord blood would not 
suffice to treat adults weighing more than 110 pounds (Kurtzberg, Drapkin, & Sugarman, 
2005). A major limitation when using cord blood grafts for transplantation in adults is the 
concern that the grafts have a low number of stem cells as compared with bone-marrow 
grafts (Laughlin et al., 2004). Reports of cord blood transplantation in adults suggest that 
hematopoietic recovery is faster with higher cell doses (Laughlin, Barker, Bambach et al., 
2001; Sanz, Saavedra, Planelles et al., 2001; Ooi, Iseki, Takahashi et al., 2002; Laughlin, 
2004). However, researchers are actively developing techniques to expand the number of 
stem cells in a unit of cord blood, using them in clinical trials, and reporting that cord 
blood transplantation in adults with leukemia and acute leukemia suggests that 
hematopoietic recovery is faster with higher cell doses (Laughlin et al., 2004; Rocha et 
al., 2004; Kharaboyan et al., 2007). Laughlin (2004) and Rocha (2004) were both 
observational studies with expected limitations which are inherent in this environment. In 
both, the effect of the stem cell source on various outcomes was analyzed by multivariate 
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methods to allow for a controlled comparison and the two investigations differed in their 
study populations and other methodological issues which may have influenced their 
results (Sanz, 2004). With much of the work in laboratory technology progressing to 
expand the UCB hemopoietic stem cells, the science is evolving so that this could solve 
the issue of reduced number of stem cells in a unit and hopefully increase transplantations 
to treat degenerative conditions such as rheumatoid arthritis and multiple sclerosis in 
adults (Sanz, 2004; Copeland, 2006). 
Another concern when a child is in need of an HLA (human leukocyte antigen) -
matched hematopoietic progenitor cell transplant (HPCT), but no match is available; the 
affected child's parents can use Pre-implantation Genetic Diagnosis (PGD) to conceive a 
child who is an HLA-matched sibling (Verlinksy, Rechitsky, Schoolcraft et al., 2001). 
The sibling then can act as an umbilical cord blood donor for the child in need of the 
transplant (Bick & Lau, 2006). This may not be the ethical choice of some parents and 
thus is not a reliable alternative method for them to consider. 
Information about Testing Diseases and Family History 
Most diseases are the result of the interactions of multiple genes and 
environmental factors. As genetic technology develops and tests become widely 
available, it has been suggested that testing be carried out on umbilical cord blood stem 
cells to identify pre-symptomatic diseases or disease susceptibility (McCullough et al., 
1994; Institute of Medicine of the National Academies, 2005, p.22, p. 169, pp. 180-183, 
pp. 185-187). Delay in reestablishing normal immune functions as donor cells restore 
recipient development of new lymphocytes, lymphohematopoiesis, plus 
immunosuppressive therapy places patients at high risk for bacterial, viral, and fungal 
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infections. In the case of donor-patient HLA (human leukocyte antigen) disparity, 
infection is an even greater problem (Eastlund, 1995; Institute of Medicine of the 
National Academies, 2005; Kharaboyan et al., 2007). Usually as a general rule the tests 
that are applied are the same series of test used for the deferral criteria as that of whole 
blood donors for risk factors. To reduce the risk of transmission to the recipient the 
criteria to determine which units are suitable for banking and the tests that umbilical cord 
blood subjected to include: ABO and RH type determination, newborn screening 
retention samples, infectious disease markers, HIV/AIDS, Hepatitis A, Hepatitis B, 
Hepatitis C, CMV by culture or DNA PCR testing, Treponema pallidum (syphilis), 
human T-cell lymphotropic virus, West Nile virus, parasitic blood diseases, 
hemoglobinopathy screen such as test negative for homozygous hemoglobinopathies, 
microbiology tests as positive CFU growth, normal genetic screen to mention a few 
(Warwick, R & Armitage, S. 2004; IOM, 2005). 
Umbilical Cord Blood transplantation requires a careful and thorough review of 
the mother's medical and social history to exclude those with a transmissible disease 
(Ballen, 2005). This may involve inquiry into the mothers' symptoms of potential 
infectious diseases as listed above or the mother has engaged in behaviors or received a 
medical treatment that increases the risk of contracting these diseases. In addition, if there 
is a lack of family medical history of inherited genetic disorders or diseases, if there is 
inappropriate affirmative responses to questions from risk behavior questionnaires, or if 
there is refusal to answer maternal and baby health questionnaire eligibility these may 
affect inclusion or non-inclusion criteria for the bank when one is desiring to send the 
UCB unit (Institute of Medicine of the National Academies, 2005, pp. 168-171). When 
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information about banking is shared with this population from a health care provider, 
especially public banking, health professionals must inform mothers about what 
infectious disease agents are being tested for, possible genetic testing the unit will 
undergo, and how they plan to be informed if the results are positive. This is a critical 
part in the intake process of public banking. This may reveal information about paternity, 
infectious diseases and predisposition or susceptibility to certain genetic diseases. 
If confidentiality is not properly protected, respected, and safeguarded the results 
of testing can have psychological and social implications for the parents and potentially 
put children at risk of suffering insurance-, education-, and employment-related 
discrimination (Kharaboyan et al., 2007). It is essential to respect the privacy and the 
health needs of women and their children as well as the privacy of the patients receiving 
the transplants (10M, 2005). Knowledge of individual risk does not always lead to better 
health but it will allow better prevention, diagnosing, and more avenues of approach in 
treatment (Guttmacher, Collins, & Carmona, 2004). This will ensure that increased 
knowledge leads to opportunities of choice affecting improved health outcomes. 
Today, with medicine at the crossroads in the era of the genomic frontier, the 
valuable tool is the family history (Guttmacher et al., 2004; Rich, Burke, & Heaton, 
2004; Scheuner, Wang, Raffel, Larabell, & Rotter, 1997). Computerized software allows 
clinicians the advantages of standardizing the family history and helping to overcome the 
gaps in obtaining and organizing the data. Linked records allow donors and recipients to 
be found, informed, and referred for care if infectious or genetic diseases detected after 
UCB stem cells have been transplanted (McCuUough et al., 1994). Doctors are allowed to 
retrace the donated UCB in the event that a child requires an autologous transplant. Also, 
in the event where a new genetic or infectious disease test becomes available, access to 
linked stored samples would allow providers to recontact donors who have previously 
agreed through informed consent to permit conducting tests on their previously donated 
samples, giving them the possible benefit of early diagnosis and treatment (Pinch, 2001). 
Many observers worry that recording the family history may lead to genetic 
discrimination in employment or health insurance (Guttmacher et al., 2004), especially 
when anything that is noted about the family members in the medical record is potentially 
discoverable as publicized in the Fall 2003 Veterans Administration Electronic Medical 
Record scandal (personal communication with Paul D. Zalusky, September, 2003) and 
witnessed by this researcher May, 2008 with medical records stolen from University of 
Utah Medical Center, Salt Lake City, Utah. Many states have laws in place to prohibit 
such discrimination (see www.genome.gov/policyethics/legdatabase/pubsearch.cjm for a 
state-by-state listing of such laws) (Guttmacher et al, 2004), and national legislation has 
been passed to incriminate those who violate the law. Beginning in 2004 are documented 
surveys that gives one reason to believe many people will welcome efforts to make the 
family history a more available tool. P. Yoon and M. T. Scheuner from the Center for 
Disease Control and Prevention, Office of Genomics and Disease Prevention had a 
personal communication with Dr. Alan Guttmacher from the National Human Genome 
Research Institute at the National Institute of Health where they asked more than 4000 
people the question "How important do you think knowledge of your family's health 
history is to your personal health?" Seventy-three percent of the survey respondents 
thought it very important, and 24 percent thought it somewhat important. However, only 
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30 percent of the respondents reported that they had actually collected health information 
from relatives in order to develop a family health history (Guttmacher et al., 2004). 
A more recent example of this is a timely initiative, July 16,2008, where there 
was a national launch of "My Records at MinuteClinic", a secure website that allows 
patients to view their MinuteClinic medical records online. This is the first retail clinic to 
partner with Google Health to help patients manage their medical information online. 
With the celebration in November 2007 seeing one million patients as a marker in the 
retail clinic competition, they are anticipating this successful. When a patient joins "My 
Records at MinuteClinic", they can also link their MinuteClinic records to a personal 
Google Health account. This was tested over several weeks in the Chattanooga and 
Knoxville markets and they have seen significant and positive interest from patients. This 
is done by offering the service at the patient sign-in kiosk and collecting their email 
address if they wish, however, it is not required to obtain health services. The patient is 
given a card with information how to access this website and to follow steps to register 
online securing two passwords to link them on their individual record. Partnering with the 
secure website, Google Health, it reassures those who fear a potential breach of 
confidentiality is far less likely to occur (personal communication on July 16,2008 with 
Alex Bollman, Project Manager, MinuteClinic, 920 Second Ave. S., Suite 400, 
Minneapolis, MN 55402). 
Financial Commitment 
The financial commitment is an issue to consider. Private Banking, sometimes 
found in the literature as commercial or family banking, fees include an upfront fee for 
families in private banking between $1,100 and $1,975 and an annual charge for ongoing 
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storage about $115 to $125 (Gajilan & Gupta, 2005; Gunning, 2006; Young, 2006; 
www.cryo-cell.com/resource-center retrieved on October 18,2006). Public Banking fee 
is initially free to the parents but the cost for the initial processing of cord blood is about 
$1,000 per unit stored. The bank incurs this initial cost and may try to recover some of 
the costs later. They can charge the insurance companies for units used with transplants 
once the need evef arises for the individual. Fees usually average $15,000 to $35,000 per 
unit (Gunning, 2006; Moise, 2005; Young, 2006) (see Appendix G for a comparison 
between the public banking systems of the United States and Europe with the private 
banking systems of the United States and Europe). 
The Asian and Indian scenario with public and private banking is a little more 
limiting. Table 1 of Appendix D gives the picture of umbilical cord stem cell banking and 
transplants in Asian countries. In India, there are no public umbilical cord blood banks 
available, although, attempts have been started in New Delhi and Chandegarh. In the 
private sector there are a few of them. Public banking would be more useful as it would 
benefit all, it would be cheaper as the costs are likely to be provided by government 
agencies and it may be useful for the minor ethnic groups. Private banks are useful for 
one who can bear the costs and hence it is expensive. It is not available to others 
including minor ethnic groups. Reliance Life Sciences (RLS) established the country's 
first umbilical cord blood bank (cord blood repository-CBR) in 2002. It has two programs 
i.e. Relicord A which collects donor umbilical cord stem cells for unrelated allogeneic 
transplants and Relicord S which collects for related sibling transplants. There are banks 
located at Bangalore, Chennai and other places. With the education status of mothers in 
India being poor, most of the women are not involved in decision-making and therefore 
legally valid consent remains a rarity. Only 34 % of deliveries occur within the 
infrastructure of health facilities and skilled personnel attend to only 42% of deliveries 
(Agarwal, 2006). 
Regulation and Quality Assurance 
The cord blood banking industry has been unregulated during its inception in the 
early 1990's when umbilical cord bank processing and cryopreservation activities had 
markedly evolved from laboratory activities (McCullough, McKenna, Kadidlo, 
Schierman, & Wagner, 2005). Since 1995, the Food and Drug Administration (FDA) 
engaged in thorough public discussion regarding a proposed regulatory approach for 
hematopoietic stem/progenitor cells obtained from placental/umbilical cord and 
peripheral blood (Harvath, 2000). In February 1997, the FDA announced its "Proposed 
Approach to Regulation of Cellular and Tissue-Based Products" (Food and Drag 
Administration, 1997). This plan was a comprehensive, risk-based system of regulation 
for cellular and tissues through innovative cellular and gene therapy products (Harvath, 
2000). Because standards have evolved over time, cord blood banks contain units that 
have different levels of quality. Some units have been placed in the usable inventory with 
incomplete test results and/or documentation and may not meet the bank's own current 
criteria: 
"There is a tension between private cord blood banks, which store blood for 
autologous or family use, and public banks, which store blood for unrelated use. There is 
an inference that private banks are taking out of circulation cord blood units which might 
otherwise be used for unrelated recipients. It is not clear that this is the case since public 
banks restrict their collection to a local network of hospitals and it is difficult for women 
outside their target population to donate. Private banks have no such restrictions" 
(Gunning & Holm, 2006, p. 19). 
In January 2005, Bone Marrow Donors worldwide reported the U. S. inventory of 
public cord blood banks from unrelated donors to be in excess of 87,000 units (Moise, 
2005). It is estimated that half of these units did not meet the criteria for a usable unit 
based on cell count and other collection issues (Institute of Medicine [IOM], 2005). One 
of the problems is the lack of enough quality cells and volume to benefit a treatment for 
adults. Since that time, the problem of cell count is being address mostly validated in 
mouse models (Encabo, Mateu, Carbonell-Uberos, & Minana, 2003; Jaroscak, Martin, & 
Waters-Pick, 1998). One of the initial studies addressing cell count out of The Chinese 
University of Hong Kong by Tsang et al., (2001) where a comparative laboratory trial 
with dextran added to bags containing umbilical cord blood (UCB) occurred. This was 
followed by sedimentation for 30 minutes pre and post sample in a semi-closed system 
which enabled volume reduction of UCB without significant quantitative and qualitative 
losses of nucleated cells (Tsang et al., 2001). There is a surge of science that is trying to 
address this issue (Bornstein et al., 2005). 
As mentioned earlier until recently there has been virtually no regulation of cord 
cell banks. In March 2004 the European Directive (2004/23/EC) on setting standards for 
quality and safety for the donation, procurement, testing processing, preservation, storage 
and distribution of human tissues and cells came into force (Gunning & Holm, 2006, 
p.21). This tissue banking directive would apply to all biobanks, including cord cell 
banks in the public sector. In the UK the Human Tissue Act 2004, which meets the 
Directive requirements, came into force on April 1,2006. Other countries, notably 
Australia, Germany, and France already impose good manufacturing practice (GMP) 
standards. Most other locations standards apply which have been developed by bone 
marrow transplant organizations or blood services such as the Foundation for the 
Accreditation of Cellular Therapy (FACT) and the American Association of Blood Banks 
(Gunning, 2004, pp. 10-15). Gunning (2006) also mentions there have probably been over 
a dozen organizations around the world setting quality standards for cord blood banking, 
all varying slightly, and accreditation has been voluntary. 
Cord blood banking involves: recruitment, consent, testing of maternal donors, 
collection, processing, cryopreservation, testing, and releasing cord blood unit to a 
transplant center. In the USA protocols have been established for these (Rubinstein, 
Dobrila, & Rosenfield, 1995) and updated in 2005 with the establishment of a National 
Cord Blood Stem Cell Program funded by the Health Resources and Services 
Administration with $10,000,000 (Institute of Medicine, 2005) but this expenditure will 
await a report on the issue from the Institute of Medicine. Meanwhile there is 
disagreement between cord blood banks and registries as to how the program should 
work (Reed, A. from New York Times, May 29,2004). The establishment of the program 
would allow for easy access to donors of different ethnic and racial populations. Units in 
public banking would be registered in a computerized program and able to be located in a 
search without the initial cost as in private banking. The units are tested for viruses, 
transmissible infectious diseases, and bacterial contamination during the prep for 
banking, so all is available in a shorter time interval. Relocation of the parents is a barrier 
to this process. The rational to contact the parent of the donor is to identify any serious 
illness identified since the birth of the donor. The parents have the right to decline to 
participate (Witte, 2005). 
Even though public banks are designed to improve donor matches for minorities 
by helping serve those patients who have a more difficult time finding donors through the 
National Marrow Donor Program (NMDP) and other international registries, a recent 
study revealed that cord blood donation from minorities has remained low. An American 
Red Cross survey in 2001 showed that 64% of donors are white, 16% African American, 
12% Hispanic, 4% Asian, 1% Native American, and 3% other (Ballen, Hicks, & Dharan, 
2002). In an effort to increase minority units, the IOM (Institute of Medicine) report 
advised that 100,000 new quality umbilical cord blood units could be collected in a 
national cord bank system (Institute of Medicine, 2005). As of May 2005 the racial/ethnic 
composition of the NMDP cord blood registry 52% white, 5% African American, 13% 
Hispanic, 5% Asian, 12% multiple race, 1% Native American, and 12% other or 
unknown (Ballen, 2005). This implies an increased recent attention to minority 
recruitment has resulted in more diverse cord blood units. 
On December 20,2005 President Bush signed into law H.R. 2520. Congress 
passed the Stem Cell Therapeutic and Research Act (Lui, 2006). The bill renames the 
National Marrow Donor Program the C. W. Bill Young Cell Transplant Program (Moise, 
2006). Along with this, $34 million in 2006 and $38 million between 2007 and 2010 are 
appropriated to establish a national cord blood inventory of 150,000 units. The belief is 
that would then be enough diversity that 90% of Americans who might need stem cells 
would be able to find a match (U.S. Congress, 2005). The bill also tasks the FDA with 
the development of licensing requirements for cord banks that will contribute units to the 
inventory. In early 2006 the California Assembly Initiatives, Assembly Bill (AB34) 
Portantino-Umbilical Cord Banking, Pilot Project was effective July 1,2007. This was a 
pilot project that would seek to diversify the umbilical cord blood supply collected in 
public blood banks. It would require the Department of Public Health to identify 5 
hospitals, in ethnically diverse areas, as voluntary participants to collect, secure a 
patient's consent for donation of, and partner with specified entities to store umbilical 
cord blood (A Publication of the Regional Perinatal Programs of California, 2007). In 
addition Senate Bill, SB 1555: Speier-Umbilical Cord Blood Banking, Education, 
Screening which will provide awareness, assistance, and information regarding umbilical 
cord blood banking options in multiple languages should be an introduction in trying to 
change the social and cultural perspectives of this practice in California. 
Cord Blood Banking in Regenerative Medicine 
The aspect of umbilical cord blood banking has gained particular impetus from 
the field of regenerative medicine. Regenerative medicine seeks to identify the 
mechanisms of self-production involved in auto-regeneration and to enhance and develop 
them into therapies for those tissues that do not regenerate spontaneously. Research is 
being conducted to find ways to culture cord blood stem cells so they can be "expanded" 
in the same way as embryonic stem cell lines (Egan, 2000) and to induce 
transdifferentiation into multipotent stem cells, rather than stem cells committed to the 
production of the blood system (Anderson, Gagae & Weissman, 2001). Umbilical cord 
blood is being used for unrelated bone marrow replacement, for example the report out of 
Japan (Mugishima, Takahashi, Nagamura, Asano, & Saito, 2002). The cord blood bank 
industry is open to paths of stem cell research and wants to participate in alternative 
options (Tse & Laughlin, 2005; Klatz, 2005; Henning et al., 2004). 
Although traditionally associated with industrialized nations, epidemic levels of 
non-communicable diseases, such as diabetes, cardiovascular diseases and cancer are 
rapidly increasing in low- and middle-income countries (Cryo-cell, 2006) on top of the 
persisting threat of infectious disease such as in India with malaria and anemia 
(Bhattachary, 2006). Now threaten by the developing world and straining health systems 
that are still struggling with persisting levels of infectious disease cord blood banks may 
be an asset. It is like there is a "double-burden" on these countries. The emerging field of 
regenerative medicine may provide new opportunities to address these health needs if 
employed with the goal of improving global health over all (Greenwood et al., 2006). 
Greenwood further implies several developing countries themselves have recognized the 
potential of regenerative medicine and have initiated Research and Development work in 
this field. This phenomenon of the "double burden" is so severe that the World Health 
Organization refers to non-communicable diseases in the developing world as "neglected 
epidemics" (World Health Organization [WHO], 2003, p. 15). "Worldwide, non-
communicable diseases now account for more deaths annually than infectious diseases", 
(http://www.who.int/dietphysicalactivity/publications/facts/chronic/en. Retrieved May 
10, 2007). By 2020, it is estimated that 7 out of 10 deaths in developing countries were 
due to non-communicable diseases (Boutayeb & Boutayeb, 2005). 
In Greenwood (2006) he discusses based on the literature regarding health 
innovation in developing countries (Juma & Yee-Cheong, 2005; Morel, 2005), as well as 
experience in studying successful biotechnology sectors in developing countries 
(Thorsteinsdottir, Quach, Daar, & Singer, 2004), how he and his colleagues believe that 
building capacity and encouraging local innovation in regenerative medicine can help 
developing countries capture benefits to address some of the health needs presented by 
this "double burden" of non-communicable and infectious diseases. Five areas where 
assessed: dedicated government funding, goods (e.g. bioengineered skin) and services 
(e.g. umbilical cord blood banking available for purchase), companies, publications, and 
academic institutions (see Appendix E for a reflection of a survey of regenerative 
medicine activities in 31 low- and middle-income countries). Greenwood further presents 
a more detailed descriptive narrative of six countries currently active in regenerative 
medicine: Argentina, China, India, Iran, Malaysia and South Africa. These countries were 
chosen because they show interesting and diverse activities in regenerative medicine, as 
well as representing various geographic regions of the world. The information in the 
narratives is well beyond the scope of this paper; however, the results of this survey of 
regenerative medicine activities in developing countries demonstrate that even though 
regenerative medicine is still an emerging field worldwide, developing countries are 
actively engaged in its pursuit. The survey identified 31 low- and middle-income 
countries and is a first step towards understanding how developing countries are building 
capacity in regenerative medicine and using it to address some of the health needs such as 
diabetes, cardiovascular disease and cancer. An understanding such as this can facilitate 
the development of health and policy both in developed countries and developing world 
needs. 
Unique Problems with Umbilical Cord Blood 
In an earlier portion of the study this researcher described the issue of umbilical 
cord blood being discarded at the birth as waste material (Gluckman, 2000; Kingsbury, 
2008). With education and the science evolving over the years on the use of UCB for 
treatment of multiple diseases (Perlow, 2002, Moise 2005) the collection rate is 
improving but it still needs to improve (Institute of Medicine of the National Academies, 
2005). Especially if infectious disease or genetic testing indicates that a child's cord 
blood is not suited for storage and transplantation or when the volume or quantity of cells 
collected is insufficient, the units may be considered not useable and then discarded 
(Kharaboyan et al., 2007). Ballen (2005) reported a common reason for approximately 
half of the cord blood units intended for banking after successful collection are not frozen 
and stored for transplant use due to a low-volume in the unit (Ballen, 2005). Now one is 
trying to educate hospital managers and obstetrical providers such as physicians/nurse-
midwives/nurses to re-think this and instead of discarding these units, stem cells 
scientists have requested access to them to advance research in stem cell therapy (H6ma-
Quebec, 2006). This possibility should be discussed with women when obtaining 
informed consent before the banking process (Institute of Medicine of the National 
Academies, 2005; Gunning, 2006, Chapter 3, pp. 17-25). 
The problem has surfaced where reports of some private companies collecting 
umbilical cord blood are presenting themselves as "Public Banks" (Gunning, 2006; 
(Saginur, Kharaboyan, & Knoppers, 2004). One of the tactics reported by Hundley 
(Hundley, 2003) is that they store blood in gratuitously and then sell compatible matches 
to research companies as well as to patients in urgent need of transplantation who are 
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willing to pay close to $15,000,000 per unit. Hundley goes on further by indicating the 
incentives to recruit women have been reported to pay obstetricians a fee for collecting 
cord blood from their patients (Kharaboyan, 2007, Gunning, 2006). The provider ought to 
fully disclose their personal commercial interests as well as those of the company with 
whom one chooses to store the cord blood (Institute of Medicine of the National 
Academies, 2005, Chapter 5, pp. 106-119; Gunning, 2006). 
It is ethically important to obtain informed consent for the donation of any cord 
blood unit regardless of the timing of collection or the potential use of the unit. Informed 
consent procedures for the donation of cord blood should follow a consistent set of 
protocols that educate the donor about the various options for cord blood use. The 
requirements should be modeled on already established criteria for transfusion of whole 
blood and other unfrozen products (Fernandez, 1998; Institute of Medicine of the 
National Academies, 2005, p. 107). Different consent methods have been used by 
different cord blood banks (Institute of Medicine of the National Academies, 2005, 
p. 108). 
The most optimal manner to promote and ensure respect for a pregnant woman's 
autonomous choice, her informed consent for the collection, storage, and use of her cord 
blood should be given prior to the labor experience and after adequate disclosure of 
information on the uses of the donated cord blood. This is especially important in the 
alternative of public banking, in which the patients may often not initiate the donation 
process. Almost all the women polled in Sugarman's (Sugarman, Kurtzberg, Box, & 
Horner, 2002) study expressed the opinion that the information about the collection of 
cord blood should be presented before the third trimester of pregnancy and could be 
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included in the informational packets that are given to others during prenatal visits. On 
the other hand, knowing that situations for optimal conditions may not occur in the labor 
and delivery area, the American Red Cross Cord Blood Program, North Central region, 
investigated a phased consent policy (Vawter, Rogers-Chysler, & Clay, 2002). The 
phased consent approach is a 3-step process involving (1) targeting information about 
cord blood banking to pregnant women; (2) allowing early labor consent to the ex utero 
collection, which is the collection from the placenta shortly after the birth experience, and 
temporary storage of cord blood; and (3) permitting post collection consent to the 
permanent storage, donation, and testing of the cord blood. Mothers who were eligible for 
intrapartum labor consent had to meet strict eligibility criteria including dilation less than 
7 cm, age older than 18 years, more than 36 weeks gestation, and no use of narcotics. 
Theoretical Model 
The transtheoretical model (TTM) of change provides an alternative way of 
grouping patients according to their stage of readiness to leam and adopt new beliefs and 
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by 
understanding the clients' readiness to change we can design our intervention to increase 
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions 
described in the model, the stages, processes, context, and markers of change, are 
designed to assist in picturing and understanding the process of change (Prochaska & 
DiClemente, 1984; DiClemente & Prochaska, 1998, pp.3-24; DiClemente, 2003). TTM 
incorporates elements of various theories of therapy, learning, and behavior change, 
hence the term 'Transtheoretical'. However, the model does not try to resolve all the 
conceptual issues and conflicts among the various theories incorporated in the model. It 
simple tries to identify and describe important elements of the process of intentional 
behavior change (DiClemente, 2007). Central to this model is the idea that people move 
through pre-defined stages when trying to improve health-related behavior. The stages 
are: 
• Pre-contemplation (no consideration of changing) 
• Contemplation (thinking about changing) 
• Preparation (making plans to change) 
• Action (actually in the process of changing) 
• Maintenance (working to prevent relapse) 
Targeting interventions according to a person's readiness to change is not a new 
idea in the world of health promotion. Prochaska and DiClemente (1982) developed the 
"stage of change model" in the field of psychotherapy in the 1980's. The model was 
originally seen as a linear model but now is often considered as cyclical because most 
people attempting to change their health behavior will have to repeat stages in order to 
learn how to maintain their behavior. The cyclical model is shown in the diagram in 
Figure 1, Appendix C (Prochaska and DiClemente, 1982; Prochaska & Levesque, 2001). 
This model is often used to design a course of action to encourage people to give 
up smoking. For example, a smoker who is in the pre-contemplation stage will need to be 
given graphic information about the health risks (Haslam et al., 2000) and may benefit 
from shock tactics. However, those smokers in the preparation stage will benefit from 
encouragement, practical advice on how to change, information to reinforce their 
motivation and perhaps skills training. 
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The same principles can be used for pregnant women learning about cord blood 
collection, banking and storage of her infant's blood at the time of birth. If she has asked 
for assistance in understanding the process, we could presume that she is past the pre-
contemplation stage. However, if she is seeking information to make a decision regarding 
public or private banking she may be further in the stages of readiness to change through 
preparation (making plans to change) or action (actually in the process of changing) thus 
making a decision. 
The transtheoretical model (TTM) of change provides an alternative way of 
grouping patients according to their stage of readiness to learn and adopt new beliefs and 
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by 
understanding the clients' readiness to change we can design our intervention to increase 
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions 
described in the model, the stages, processes, context, and markers of change, are 
designed to assist in picturing and understanding the process of change (DiClemente, 
2003; DiClemente & Prochaska, 1998, pp.3-24; Prochaska & DiClemente, 1984). The 
cyclical model is shown in the diagram in Figure 1, Appendix C (Prochaska and 
DiClemente, 1982; Prochaska & Levesque, 2001). 
The same principles can be used for pregnant women learning about cord blood 
collection, banking and storage of her infant's blood at the time of birth. If she has asked 
for assistance in understanding the process, we could presume that she is past the pre-
contemplation stage. However, if she is seeking information to make a decision regarding 
public or private banking she may be further in the stages of readiness to change through 
preparation (making plans to change) or action (actually in the process of changing) thus 
making a decision. A Stage of Readiness Scale was used and adapted from Prochaska et 
al., (Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander, Hollingsworth, O'Connor, & 
Meltzer, 1994) (see Appendix H, Table 1). 
It is important to address any assumptions or motivations the donors might have. 
The attitudes of mothers toward the collection of cord blood units generally reflect their 
level of knowledge of the process (Sugarman, Kaplan, Cogswell, & Olson, 1998; 
Fernandez, Gordon, Van den Hof, Taweel, & Baylis, 2003). Perceptions about the 
collection process can be misleading, the associated risks, and the availability and access 
of units, should they be needed in the future, are common among cord blood donors. In 
one study, women failed to appreciate their alternatives to donating cord blood to a public 
bank. Almost thirty-three percent (33%) did not understand that they had the option of 
discarding their cord blood at delivery, whereas just over fifty percent (50%) were aware 
of the option of placing cord blood units in a private bank (Sugarman, Kurtzberg, Box, & 
Horner, 2002). Another study showed that ninety-five percent (95%) of new mothers say 
had they known about public cord blood donation, they would have donated per a recent 
report (Kingsbury, 2008) of a National Marrow Donor Program (NMDP) survey. 
"The potential is so significant," says Dr. Jennifer Willert, a stem-cell transplant 
specialist at the Rady Children's Hospital in San Diego. "Not to have families know 
about the possibility of banking, that's tragic." (Kingsbury, 2008) 
Other donors view public banking as a less expensive way to preserve and gain 
access to their children's cord blood in the future rather than contracting with a private 
bank. Almost one-half of the respondents indicated that the reason they chose to donate 
their cord blood to a public bank was to protect their child's future health (Sugarman et 
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al., 2002; Institute of Medicine of the National Academies, 2005, p. 111). Not having a 
property claim on public donation of cord blood is an important issue parents need to 
comprehend at the time of informed consent. 
The researcher was interested in examining whether the variables of age, 
gestational age, level of parity (number of children), marital status, race/ethnicity, 
religion, highest level of education completed, economic status and method of payment 
for prenatal care are predictors of knowledge of cord blood donation. 
Umbilical cord cell transplantation has evolved over the last 15 years from being 
an experimental procedure to an accepted treatment for a number of hematological 
diseases and genetic disorders. During the evolution the banking of this human tissue has 
increased exponentially around the world. The proliferation of private cord cell banks has 
been particularly strong in the USA and Asia while, in Europe, where there are one or 
two old established private banks, the emphasis has been on public cord cell banking. 
But, whether in the private or public cord cell banking sector, there remains alternate 
quality assurance standards that need addressing. This will become particularly important 
if cord blood stem cells are to play an important part in the cellular therapies of 
regenerative medicine in the future. As the utility of these cells increases countries may 
have to consider whether cord blood should be collected from all newborns. This will be 
a costly process and maybe the promotion of cord blood donation but with the 
acknowledgement that the right to private storage may prove a practical way forward for 
some and not for others. It is also clear within this frontier of science that new ethical 
questions will continue to arise. 
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Implications to the Body of Nursing Science & Gaps in the Literature 
Essentially the limited or absence of nursing science, theory building and research 
in this field of contributing stem cells in cord blood collection, donation, and future 
outcomes needs to be recognized and further supports the need for this study. The 
following are areas where there is a gap in the literature supported by my prior literature 
review: 
• Knowledge deficit on types of banking for cord blood: Private and Public 
• Knowledge deficit on what process of regulation matches private versus public 
blood banks 
• Disagreement on insufficient number of hemopoietic stem cells in umbilical cord 
blood and how it needs to be packaged 
• Discrepancies regarding information related to testing for diseases and what is 
needed in the family history 
• Discrepancies related to the financial commitment 
• Issues surrounding what are the required regulatory and quality assurance issues of 
collection, donation, and storage 
• What avenues of disease treatment and regenerative medicine are presently 
occurring and what is to come in the future. 
(Kingsbury, 2008; Institution of Medicine(IOM), 2005 & 2006; Kurtzberg, Drapkin, & 
Sugarman, 2005; Eastlund, 1995; Kharaboyan et al., 2007; Gunning & Holm, 2006; 
McCuUough et al., 2005; Greenwood, 2006). 
Chapter III 
Methodology 
Method reflects the researcher's philosophical beliefs about the nature of reality 
and is situated in, and flows from, one's world-view and the nature of the question being 
researched. According to van Manen, "Lived experience is the starting point and the end 
point of phenomenological research" (van Manen, 1997, p.36). Lofland addresses the 
lived experience when he stated, "Today's solutions may become tomorrow's problems; 
tomorrow's problems may provide special research opportunities the day after" (Lofland, 
Snow, Anderson, & Lofland, 2006, p. 32). The research process begins with the 
awareness of a phenomenon as it exists in the world. Who would have known thirty-five 
years ago when this researcher a new graduate nurse routinely collecting cord blood at a 
birth to determine the baby's blood type that some day one would be collecting it for 
stem cell research on a baby. This researcher has chosen to do a quantitative method 
because qualitative results are inadequate by themselves. When the researcher assesses 
the initial quantitative results the qualitative data are needed to help explain or build what 
is really going on with the sample (Creswell & Piano Clark, 2007, Chap. 4 & 5). The 
researcher has chosen to do a Survey Design which may hopefully lead to research 
opportunities in the future with a mixed method as an Explanatory Design. 
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The purpose of this chapter is to describe the quantitative design and methods 
chosen to conduct this research. The qualitative analysis was limited to only 11 
interviews out of the total, thirty in the population, for this study and there was limited 
time to go into depth due to time constraints and financial limitations. This is an area the 
researcher needs to explore in the future. This section begins by addressing the research 
questions and hypotheses, the specific research design implemented, including the 
desired sample, recruitment of participants, and measurement instruments. This includes 
a discussion of descriptive and inferential statistics used to analyze the data, data 
collection procedures, and data management and analysis. Issues related to human 
subjects discussed, which includes confidentiality, consent, risks/benefits, and 
communication with participants. 
Method 
Research that includes uncovering meaning from a feminist perspective is a 
beginning step towards understanding a woman's lived birth experience. Because much 
of a woman's lived birth experience is hidden due to privacy and it being one of the most 
intimate moments in her life, a. feminist hermeneutic phenomenologicol perspective was 
used to provide deeper understanding of the lived experience of women and the decision 
to donate cord blood at her child's birth. The Survey Design is well suited to this study 
because it is a step toward how to assess a woman's knowledge in the use of this method 
of stem cell collection. The design is suitable as the researcher wants to form groups 
based on quantitative research (Morgan, 1998; Tashakkori & Teddlie, 1998) and the 
researcher will use the quantitative participant characteristics to guide purposeful 
sampling for a qualitative phase (Creswell, Piano Clark, Gutmann, & Hanson, 2003) in 
future research opportunities. The researcher anticipates one may need qualitative data to 
explain significant or non-significant results, outlier results, or surprising results (Morse, 
1991). 
Stem cells from umbilical cord blood form one of the most commonly banked 
types of human tissue. Birth is a time when stem cell collection is an option through 
umbilical cord blood collection. Despite over 74 million births per year in the world of 
which four million in the United States (World Watch Institute, 2006, p.75), many people 
remain unaware of human umbilical cord blood collection (Cryo-cell, 2006). Originally 
stored for the treatment of hematological disorders these stem cells have now been found 
to be more versatile for potential use in the treatment of a broader range of disorders and 
diseases and may be particularly valuable in cell therapy and regenerative medicine 
(Gunning & Holm, 2006, p. 17;Waldby, 2006). 
The storage of umbilical cord cells has not been without controversy and there is a 
rapidly growing private sector involvement. Over the last two decades umbilical cord 
blood has proved an effective substitute for bone marrow in the treatment of blood 
disorders, and most nations in the developed world have public programs for the 
harvesting and storage of cord blood for allogenic transplantation (Garcia & 
Torrabadella, 2006; Waldby, 2006). Yet, a number of ethical issues continue to be 
debated involving questions of regulation and quality assurance, ownership and 
commercialization and patenting. In this paper the researcher will first present the 
historical background of related and unrelated cord blood to establish the legitimacy of 
the science, public versus private banking, regulation and quality assurance of banking 
and the worldwide influence cord blood banking has on regenerative medicine. 
Tremendous confusion remains about different sources of stem cells and their use 
in the minds of the government, the public, and the medical community. Until 1988 
(Smith & Thomson, 2000) and April, 2006, (Cryo-cell, 2006) blood that remained in the 
umbilical cord and placenta respectfully after delivery used to be routinely discarded. 
Now several studies have confirmed with similar results this blood is known to contain 
hematopoietic stem cells and pluripotent mesenchymal cells (Moise, 2005); 
undifferentiated cells that can develop into virtually any type of blood cell in the human 
body; and provides a better alternative to bone marrow transplantation to treat an 
expanding list of malignant, benign, and inherited disorders (Perlow, 2002) (see 
Appendix B for a list of diseases treatable with stem cells from umbilical cord blood). 
The purpose of this study is to investigate pregnant women's knowledge of cord 
blood collection and what decision-making process they experience for a decision on 
donation of cord blood. The research question: What characteristics during a woman's 
pregnancy are related when making a decision for cord blood donation at birth? 
The following hypotheses were tested and are listed below: 
Hypotheses: 
1) Women are not knowledgeable about their options to store infant's cord blood 
(CB) with a storage bank for possible future use by the child or other family members. 
The transtheoretical model (TTM) of change provides an alternative way of 
grouping patients according to their stage of readiness to learn and adopt new beliefs and 
behaviors (Prochaska & DiClemente, 1998). Recent research suggests that by 
understanding the clients' readiness to change we can design our intervention to increase 
the chance of successful implementation (Haslam & Haslam, 2000). The dimensions 
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described in the model, the stages, processes, context, and markers of change, are 
designed to assist in picturing and understanding the process of change (DiClemente, 
2003; DiClemente & Prochaska, 1998, pp.3-24; Prochaska & DiClemente, 1984). The 
cyclical model is shown in the diagram in Figure 1, Appendix C (Prochaska and 
DiClemente, 1982; Prochaska & Levesque, 2001). 
The same principles can be used for pregnant women learning about cord blood 
collection, banking and storage of her infant's blood at the time of birth. If she has asked 
for assistance in understanding the process, one could presume that she is past the pre-
contemplation stage. However, if she is seeking information to make a decision regarding 
public or private banking she may be further in the stages of readiness to change through 
preparation (making plans to change) or action (actually in the process of changing) thus 
making a decision. A Stage of Readiness Scale used adapted from Prochaska et al. 
(Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander, Hollingsworth, O'Connor, & 
Meltzer, 1994) (see Appendix H, Figure 2). 
The researcher is interested in examining whether the variables of age, gestational 
age, level of parity (number of children), marital status, race/ethnicity, religion, highest 
level of education completed, economic status and method of payment for prenatal care 
are related characteristics to the knowledge of cord blood donation. 
Research Design 
This research presents a survey with a descriptive correlation design using 
convenience sampling, utilizing a cross-sectional design to assess factors that may lead to 
cord blood collection, banking and storage. The design will use t-testfor independent 
means and Analysis of Variance (ANOVA) for analysis. The design and method are 
intended to determine if the knowledge level of two factors: public cord blood banking 
and storage OR private cord blood banking and storage is clearly understood by pregnant 
women and their partners. Since the goal is to predict values of the dependent variable, 
cord blood banking (public or private), which is categorical and dichotomous, the 
researcher is attempting to predict membership into one of two or more "groups". The 
researcher is testing if there is statistical significance between the differences of the two 
sample means. A statistician named William Gosset developed the t-test for exactly this 
type of situation (Fred Pyrczak, 2010, p. 119). As a test of the null hypothesis, the t-test 
yields a probability that a given null hypothesis should be rejected. When the t-test yields 
a low probability that a null hypothesis is correct, the researcher usually rejects the null 
hypothesis. There are three basic factors which interact with each other in determining 
the probability level: 1) The larger the samples, the less likely that the difference between 
two means created by sampling errors. When large sample are used, the t-test is more 
likely to yield a probability low enough to allow rejection of the null hypothesis than 
when small samples are used. 2) The larger the observed difference between the two 
means the less likely that the difference created by sampling errors. 3) The smaller the 
variance among the participants, the less likely it is that the difference between two 
means created by sampling errors and the more likely the null hypothesis rejected (Fred 
Pyrczak, 2010, p. 120; Shott, 1990, pp. 122-125). 
The other analysis which was used was the One-Way ANOVA. Analysis of 
variance (ANOVA) is a closely related statistical procedure to the t-test but is used to test 
the difference(s) among two or more means (Holcomb, 2009, p. 149; Fred Pyrczak, 2010, 
p. 127). The t-test cannot give you the difference among more than two means. When 
ANOVA is done, the result also uses similar methodology to the t-test to determine if 
there is a statistically significant difference in means by calculating in F-value. 
One advantage of the research design is the ease which the use of the instruments 
will provide, as well as their brevity. Another potential advantage includes patients 
understanding of private versus public banking and the process in each bank. It will 
minimize potential confusion to pregnant women and their partner's regarding the 
potential capability of stem cells in private and public cord blood banks that are 
advertized in many different venues including the internet. A potential disadvantage 
would be possible discourse between pregnant women and their partner's due to 
differences in the final decision to donate cord blood or not donate. Finally, the worst 
disadvantage would be the decision not to donate at all with a possible disadvantage to 
their lives should they need it. 
Sample Size and Power Analysis 
A power calculation determines the needed sample size to detect a particular 
effect. Based upon the rule of thumb 15-20 subjects per independent variable, 
approximately 45 to 80 participants required to achieve sufficient power. The three 
independent variables measured from the questionnaire are: 1) patients' sources of 
knowledge about cord blood donation, 2) patients' beliefs about cord blood collection, 
storage and use, and 3) patients' knowledge about current indications for cord blood 
transplantation. 
The power of the test of the null hypothesis is "the probability that it will lead to 
the rejection of the null hypothesis" (Cohen, 1988, p.4) and (Munro, 2005, pp. 141-143). 
A power of 0.80 means there is an 80% chance of rejecting the null hypothesis. The 
higher the desired power, the more subjects required. Cohen suggests that for the 
behavioral scientist, a power of 0.80 is reasonable, given no other basis for selecting the 
desired level (Munro, 2005, p. 141). 
The effect size for the /test is the difference between the means of two groups 
divided by the standard deviation for the measure. Cohen's moderate effect size is set at 
0.5, which means half of a standard deviation unit. Given an effect size of .70 and a 
power of .80 the Cohen table indicates this researcher will need 33 subjects (Cohen, 
1988, p.55). 
Each time an ANOVA test is conducted one runs the risk of a Type I error 
(rejecting a true null hypothesis). The probability level that sets the point at which one 
rejects the null hypothesis also is the level of risk with which one is comfortable. When 
calculating multiple t-tests on independent samples that are being measured on the same 
variable, the rate of error increases exponentially by the number of tests conducted. 
Instead of using a series of individual comparisons, we examine the differences among 
the groups through an analysis that considers the variation across all groups at once. This 
test is the analysis of variance (ANOVA). 
Using ANOVA an effect size of .30 (Cohen, 1988, p.355 defines a moderate 
effect size as .25, which with two groups is still half of a standard deviation unit) and still 
using a power of .80 we would need to have 27 subjects in the group (Munro, 2005, 
p. 154; Cohen, 1988, p.384). 
However, the researcher will also attempt to use Pearson's correlation coefficient 
and when determining the sample size for comparison of two normally distributed 
interval variables there are three needed elements as well. They are effect size, alpha, and 
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power. Effect size is the absolute value of the difference between the expected correlation 
and a correlation of zero. For example, if this researcher expects the correlation to be 
-0.4 the effect size would be 0.4. (| -0.4 - 0| = 0.4). The absolute difference is used 
because for a sample size calculation it does not matter whether the correlation is positive 
or negative. The alpha level is the probability of falsely rejecting the null hypothesis, that 
is rejecting the null hypothesis when it is actually true (Type I error). There is no correct 
alpha level. The researcher will choose an alpha level based on what is reasonable (Katz, 
2006, pp.132 & 135). Most studies accept a 5% chance of rejecting the null hypothesis 
when it is really true. Therefore, the researcher will usually specify alpha as 0.05. The 
power is the probability of rejecting the null hypothesis if the actual effect is as large as 
the estimated effect size. Although this researcher would like a 100% chance of rejecting 
the null hypothesis when it is false there is no sure bet this will happen. Usually one 
settles for a 0.80 or 0.90 probability (80% to 90% chance) of rejecting the null hypothesis 
if it is false (Katz, 2006). 
Sample 
The research design involves assessment of women who voluntarily want to 
inquire about the pros and cons of cord blood donation in the San Diego county area. 
Methodology will include use of instruments, or standardized measures, to assess sources 
of knowledge about cord blood donation; beliefs about cord blood collection, storage 
and use; their knowledge about current indications for cord blood transplantation; This 
was measured using the Fox Questionnaire (Fox et al., 2007) and a Readiness for Change 
Scale (Prochaska & DiClemente, 1998) titled as the Cord Blood Collection Survey. Basic 
demographic information and data concerning age, gestational age, number of children 
(parity), marital status, race/ethnicity, religion, highest level of education completed, 
economic status, and method of payment for prenatal care was analyzed. The factors 
were analyzed in their relationship to women's knowledge level of cord blood collection, 
banking and storage (donation). 
Because there was a concern about obtaining enough women for the sample size, 
several options were explored. A convenience sample was recruited through the 
placement of adds in a local newspaper, San Diego Union Tribune, and a flyer available 
in local church congregations to allow for a convenience sample by volunteering and 
non-randomization. There were flyers in the waiting rooms of two multicultural clinics 
where most of the women were of childbearing age. This was the first method at 
obtaining participants. The inclusion criteria searches for pregnant women; the majority 
of participants were English speaking women even though some were bilingual. 
However, there were translators available for Spanish and Arabic translation if needed. 
The advantage of the sampling technique was ease in implementation and it was 
preferred that a naturally formed group of volunteers participate in the study. The 
disadvantage was that this was not randomized to all women. The research procedure 
process was available to conveniently include a marginalized population of English and 
non-English speaking women; it did not eliminate the possibility of systematic 
differences among the participants and the environment of the experiment could have 
affected the outcomes. However, the researcher believes this was a representative sample 
of women potentially in their childbearing years who were delivering at our hospitals in 
the geographical area. The local newspaper advertisement would be read by those women 
who are literate, seek an interest in participating in this research, and it was distributed to 
a wide net of subscribers as well as availability of the newspaper on the internet. In order 
to obtain additional participants this was advertised in local church bulletins. The 
researcher included church going women as they are usually family oriented and may be 
representative of the pregnant population. To maintain anonymity and confidentiality the 
surveys and questionnaires were coded with the individuals last 4 digits of their phone 
number. All information was secured by the researcher using password protected files 
and locked storage. 
Operational Definitions 
Dependent Variable: the decision to collect cord blood (1) or not collect cord 
blood (0) and it will be to a private bank (1) or public bank (0). This was measured by the 
score on the Cold Blood Collection Survey. So the total score of each individual was the 
dependent variable. 
Dependent variable: Stages of Readiness as described in the transtheoretical 
model (TTM) by Prochaska & DiClemente (Prochaska & DiClemente, 1998): 
Pre-contemplation (no consideration of changing) 
Contemplation (thinking about changing) 
Preparation (making plans to change) 
Action (actually in the process of changing) 
Maintenance (working to prevent relapse) 
Independent Variables: The main independent variable (IV) was the patients 
identified by their gravida as primigravida OR multigravida. Additional variables which 
included: A) Patients' sources of knowledge about cord blood donation; B ) Patients' 
beliefs about cord blood collection, storage and use; and C) Patients' knowledge about 
current indications for cord blood transplantation. 
Demographic Variables or Control Variables for Logistic Regression (these 
contain a mix of continuous and categorical variables): age; gestational age in weeks 
calculated from last normal menstrual period OR confirmed by 16-20 week ultrasound; 
level of parity (number of children); marital status; race/ethnicity; religion; highest level 
of education completed; economic status; and method of payment for prenatal care. 
Data Collection Procedures with Instruments 
Each participant completed a self-administered survey on her first encounter with 
the researcher at anytime during the gestation of the pregnancy along with the incentive 
that at completion of the survey they would be enrolled in a lottery and be eligible to win 
a gift certificate valued at $100. All surveys were cross-sectional, self-administered and 
collected by the researcher. The baseline survey includes a staging algorithm designed to 
assess individuals' stage of cord blood donation intention, and a second staging algorithm 
designed to assess individuals' stage of communicating their cord blood donation 
intention with their partner. Staging algorithms were adapted from previous research with 
other health behaviors (Prochaska, Velicer, & Rossi, 1994). Wording for these staging 
algorithms is presented in Figure 2 in Appendix II. The subject will circle the comment 
that most represents the intent of the individual and will circle the comment that most 
represents the status of communication with the individual spouse or father of the baby 
(FOB). 
An explanation of the study was provided followed by obtaining informed written 
consent. All women who enter into the study were offered an anonymous questionnaire 
to complete. The Fox Questionnaire (Fox et al., 2007) includes multiple choice questions 
regarding the sources of information about cord blood, whether they plan to have their 
cord blood collected and stored, whether they plan to donate to a. public bank or store 
with a private/commercial bank, the reasoning behind these decisions {sources of 
knowledge, independent variable 1), the beliefs about the potential uses for cord blood 
collected (independent variable 2), and their knowledge about current therapeutic uses of 
cord blood transplantation (independent variable 3). The questionnaire was developed to 
collect demographic characteristics, (Table 1); Patients' sources of knowledge about cord 
blood donation, (Table 2); Patients' beliefs about cord blood collection, storage and use, 
(Table 3); and Patients' knowledge about current indications for cord blood 
transplantation, (Table 4) (see Appendix I, Tables 1-4). The researcher conducted a face-
to-face interview with each participant to establish a positive rapport with them only 
before answering the questionnaire. The participants self-administered the survey. No 
information was offered at that time regarding education on the differences between 
public versus private cord blood donation. Every third participant in the survey was 
selected to participate in a one-on-one 60 minute interview using the Interview Guideline 
for Cord Blood Donation (see Appendix K). Consent Assent is in Appendix L (see 
Appendix L). 
Measures 
The instrument, Readiness for Change, used for the survey in Table 1 (see 
Appendix H), was adapted from a tool in the public domain created by Prochaska and 
DiClemente (1982). It is a staging algorithm for readiness to change. This tool has 
consistently demonstrated high reliability and validity for general population use, as well 
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as with patients with behavior changes, and used quite proficiently throughout the 
research community today for studying all types of clinical trial with patients in use of 
any type of decision-making process. When doing my literature search the tool came up 
262 times on the internet. The tool meets content validity as the items measure the 
content they were intended to measure such as the individuals' stage of cord blood 
donation intention, and a second staging algorithm designed to assess individuals' stage 
of communicating their cord blood donation intention with their partner. This gave a 
discrete dichotomous variable on the survey with only two classifications (Yes/No) to 
answer the stage of readiness. 
The questionnaire used in Table 1, 2,3,4 of Appendix I is adapted from Nathan 
Fox (Fox et al, 2007) and for purposes of clarification this titled the Fox Questionnaire. 
This questionnaire a reflection of categories in age, gestational age, level of parity 
(number of children), marital status, race/ethnicity, religion, highest level of education 
completed, economic status and method of payment for prenatal care. There was 
categorical, nominal, ordinal, interval, and odds ratio scales of measurement. This is the 
bases of the descriptive statistics intended to support the results reflective in the 
frequency distribution of the mean, median, and mode in each category (see Appendix I, 
Table 1). These measures of central tendency will be represented in standard deviations 
(sd) of the sample and not the population (SD) to describe the variability. The variability 
is the amount by which participants vary or differ from each other. In other words, the 
standard deviation, (sd), of the sample will be compared to the population, (SD), in the 
literature to examine variability. 
51 
The Fox Questionnaire will also reflect the patients' sources of knowledge about 
cord blood donation; patients' beliefs about cord blood collection, storage and use; and 
patients' knowledge about current indications for cord blood transplantation. This will 
allow one to assess pregnant women regarding their basic understanding of cord blood 
donation, beliefs, and knowledge on current indications for transplantation. This will then 
be compared to Stages of Readiness placing them in categories of an ordinal scale (see 
Appendix J, Table 5). The inferential statistics will allow one to make inferences about 
the characteristics of the population from knowledge of the corresponding characteristics 
of the sample. 
The questionnaire/survey met reliability as the answers were from the individual 
without a third party asking the questions for possible bias or misrepresentation unless a 
translator was used and this did not occur with this researcher in this population. Content 
validity was assessed because the items in the questionnaire/survey where measured on a 
scale unique to each individual which is what the questionnaire/survey was intended to 
measure. The predictive or concurrent validity was assessed, i.e. that the more 
pregnancies one experiences the more knowledgeable one would be regarding cord blood 
donation and use. Construct validity was assessed in the questionnaire/survey by the 
items which measure hypothetical constructs or concepts regarding pregnant women's 
beliefs regarding cord blood collection, storage and use. 
Data Management and Analysis 
The descriptive statistics will describe the distribution of the independent 
variables such as age, gestational age, level of parity (number of children), marital status, 
race/ethnicity, religion, highest level of education completed, economic status and 
52 
method of payment for prenatal care by using measures of central tendency and of 
variation. This was done with a frequency distribution from which the mean, median, and 
mode were derived. The computer program in this study used the PASW Statistics 
GradPack 18 for Windows®/Mac® (Arbuckle, 2009) on the Fox Questionnaire (see 
Appendix I). 
The inferential statistics will have multiple analyses using t-test and ANOVA 
using PASW Statistics GradPack 18 for Windows®/Mac® (Arbuckle, 2009). To begin the 
researcher assessed using a null hypothesis: 
Ho= There is no difference in the mean score of Cord Blood Collection (CBC) Survey 
fj\ = Pregnant women who speak with their obstetrician 
H2 = Pregnant women who do not speak with their obstetrician 
^ = ^ 1 - ^ 2 = 0 
By using the t-test one seeks to disprove the null hypothesis with different variable 
means: that is, there is no difference between the two means. The t-test is (Katz, 2006, 
p. 84) calculated as the difference between the two means divided by the standard error of 
that difference: 
t= mean of sample 1 - mean of sample 2 
standard error of difference between mean 1 and mean 2 
The computer produces the equal (pooled) variance formula and the unequal 
(equal variances not assumed or separate) variance formula. The first task is to look first 
at the Levene's test. If the significance level exceeds .05, the equal variance (pooled) 
results are used; if the significance level is less than .05, the unequal (separate) variance 
results will be used (Munro, 2005, p. 143) and I would reject the null hypothesis (Katz, 
2006, p. 85). 
Testing the association of a nominal variable with an interval parametric variable 
(e.g., the association of ethnicity and Cord Blood Collection Survey score) is similar to 
testing the association of a dichotomous variable with the interval parametric variable 
(e.g., the association of Cord Blood donation "Yes/No" with the Cord Blood Survey 
score). In both situations one will be comparing means. The difference is that with a 
nominal variable, there are three or more groups. In such situations, use ANOVA (Katz, 
2006, p. 88). 
An ANOVA tests the null hypothesis that there is no difference in the means of 
different groups; "in other words, any differences between the means are due to random 
variation" (Katz, 2006, p. 88) and indicates the probability that the null hypothesis is 
correct (Patten, 2007, p. 127). According to the null hypothesis, all groups were from the 
same population (a local prenatal care/obstetrical clinic) and each of their scores come 
from the same populations of measure (Cord Blood Collection Survey). Any variability 
of the scores can be seen in two ways: First, the scores vary from each other in their own 
group; this variation is called "within-group variation". Second, the groups vary from 
each other; this variation is call "between-group variation". Together, the two types of 
variation, prenatal patients characteristics and Cord Blood Collection Score, add up to the 
total variation (Munro, 2005, pp. 154-157). 
ANOVA produces an F-value. The F-value is the ratio of the between-groups 
variance to the within-groups variance (Katz, 2006, p. 88). 
F'= between-groups variance (variance calculated based on entire sample) 
within-groups variance (variance calculated separately for each group) 
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Because one-way ANOVA calculations are extremely detailed the margin of error 
is high and it is easy to make mistakes when doing them by hand. Therefore computer 
output is recommended and the researcher here is using PASW Statistics GradPack 18 for 
Windows®/Mac® (Arbuckle, 2009), otherwise known as the "new SPSS 18.0". Using this 
software the j?-value for F statistic is given. The format shown in table below in Figure 
















Figure 3.1 One way analysis-of variance table format (Shott, 1990, p.151) 
Strengths and Limitations of Methods 
If the difference between the means is small or if the error in the measurement of 
the difference is large compared to the difference in the means, then the /-value will not 
reach statistical significance. The t-test may not be valid for variables with non-normal 
distributions. If the mean is not an accurate measurement of the center of the distribution, 
then a test based on the comparison of means may not be valid. The t-test is actually a 
very robust test because the statistical software is built to take into account situations 
when the variance may be unequal. Unequal variance is especially a problem when the 
sample sizes are unequal and smaller sample is associated with the larger variance. When 
variances are unequal, the researcher will need to perform a t-test for unequal variances 
Levene's test is one of the tests to calculate equality of variances. This is in the computer 
program where the / value is calculated two ways: assuming equal and unequal variances 
(Katz, 2006, p. 85). If the variances are equal then report the value of the t-test assuming 
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equal variance. If the variances are unequal report the value of the t-test assuming 
unequal variance. 
A limitation of the t-test is that it does not give the reader direct information on 
the numeric difference between the two groups (Katz, 2006, p. 85). A useful method of 
calculating the difference between the two groups is to obtain the mean difference 
between the two groups (i.e., mean difference = mean 1 - mean 2) and then take the 95% 
confidence interval of that difference (Glantz, 2002, pp.200-9). The difference between 
the means would be considered statistically significant if the 95% confidence interval of 
that difference excludes zero (Katz, 2006, p. 85). 
When performing ANOVA with computer software it can perform one-way 
ANOVA calculations but it cannot determine whether independence or normal 
assumptions are adhered to in a reliable fashion. This is the responsibility of the 
researcher. If the computer is given data that violate assumptions, it will carry out the 
analysis anyway which could then be misleading (Shott, 1990, p. 152). 
Another important limitation of ANOVA is that it does not indicate where the 
difference lies. A large F just tells you that you can reject the null hypothesis that all the 
means are the same (Katz, 2006, p. 89). For example, if the researcher compares three 
groups A, B, and C, there are a total of seven possible ways that the groups may differ 
from one another (Katz, 2006, p.89): 
A is different than B (but not different than C) 
A is different that C (but not different than B) 
B is different that C (but not different than A) 
A is different from both B and C (which are not different from one another) 
B is different from both A and C (which are not different from one another) 
C is different from both A and B (which are not different from one another) 
A and B and C are all different from one another 
To see where the differences lie, it is necessary to perform pairwise comparisons 
of the groups using a t-test. "The important difference is that when you use the t-test for 
pairwise comparisons you are performing multiple comparisons. When making multiple 
comparisons you should set more stringent criteria (i.e., a lower P-value) before rejecting 
the null hypothesis" (Katz, 2006, p.90). This is to prevent a Type I error. 
There are several important issues related to the use of statistical analysis using t-test and 
analysis of variance. First, there is the issue of the ratio of participants to variables 
included in the analysis. Problems may occur if too few participants relative to the 
number of predictor variables exist in the data (Mertler, 2005). Also, post-hoc 
comparisons with ANOVA can be a problem as well. 
Human Subjects 
Risks and Benefits 
Participation in research may involve risks or discomforts. Potential risks and 
benefits were disclosed in the informed consent (see Appendix L). Although this is 
strictly a descriptive correlational study, completion of the questionnaires may cause 
participants to experience anxiety, or discomfort and possible discourse with their 
significant other. To avoid this, the questionnaires were administered in a private setting 
within the university where the participant can answer without fear of interruption from 
family or other personnel. The participants were instructed that they need not answer any 
question they wished to omit. After the woman has finished, the participant will place the 
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completed questionnaires in an envelope that is labeled with a unique patient identifier, 
known only to the investigator. The participant will seal the envelope and give it to the 
researcher who will analyze the results at a later time in a private setting. 
There may be no direct benefit from participation in this study. However, several 
possible benefits exist. One possible benefit is early identification of level of knowledge 
which will alert the individual mother of concerns regarding her possible selection to 
cord blood use and preparation for the birth of her child and her expectations. This gives 
her an opportunity to decide if she chooses to discuss with her significant other the pros 
and cons of different types of cord blood collection for use. This will allow her to see if 
she is ready to even make a decision regarding this important issue and what she may 
need to do to get the information to complete a well informed decision regarding cord 
blood use. All of these interventions may inform and improve the participant's health 
status and family preparation for future years to come. 
Protecting subjects from any potential risks 
To minimize potential risks the participants were volunteers and there was no 
coercion of any type used. If there is a question that she desires not to answer on the 
questionnaires she will not be eliminated from the study. If she desires more information 
regarding this issue after answering the questionnaires, the researcher will give written 
handouts explaining the information. This will not be distributed beforehand as the 
researcher desires to get nonbiased information in the beginning. If there is discourse 
between couples around this subject, a counseling service was provided for the couple as 
social support per their request (see consent form Appendix L and see recruitment flyer 
Appendix M). There was a Spanish translation of the Flyer, Consent, Readiness Scale, 
Fox Questionnaire and Interview Questions done by a paid and certified linguistic 
assistant at a local university working towards a degree to be a psychologist in a dual 




The purpose of this study is to investigate pregnant women's knowledge of cord 
blood collection issues and what decision-making process and complexities they undergo 
regarding or in conjunction with cord blood donation at the birth of their infant. The 
survey assessment items were selected from the Fox Questionnaire and patient's 
identification of the stage of readiness in their decision regarding cord blood collection 
for donation at the time of the study. The research question: What characteristics 
during a woman's pregnancy are related when making a decision for cord blood 
donation at birth? 
The following hypotheses tested and are listed below: 
Hypotheses: 
1) Women are not knowledgeable of their options to store infant's cord blood 
(CB) with a storage bank for possible future use by the child or other family members. 
The researcher is interested in examining whether the variables of age, gestational 
age, level of parity (number of children), marital status, race/ethnicity, religion, highest 
level of education completed, economic status and method of payment for prenatal care 
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are related to knowledge of cord blood donation. First, a descriptive profile of the sample 
was presented, followed by the results specific to the research questions. 
The same principles in the Transtheoretical Model can be used for pregnant 
women learning about cord blood collection, banking, and storage of her infant's blood at 
the time of birth. If she has asked for assistance in understanding the process, we could 
presume that she is past the pre-contemplation stage. However, if she is seeking 
information to make a decision regarding public or private banking she may be further in 
the stages of readiness to change through preparation (making plans to change) or action 
(actually in the process of changing) thus making a decision. A Stage of Readiness Scale 
was used and adapted from Prochaska et al. (Prochaska, Velicer, & Rossi, 1994; Quinn, 
Alexander, Hollingsworth, O'Connor, & Meltzer, 1994) (see Appendix H, Figure 2). 
The responses to the survey pertaining to the participants and the spouses' 
partners are stages of readiness: pre-contemplation; contemplation; preparation; action; 
and maintenance are presented in Table 4. The majority of women and their partners 
(52%) responded that they are in the pre-contemplation stage. Table 4.1 below reflects 
the outcome of the Stages of Readiness on the Stages of Readiness Scale. 
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Table 4.1 Stages of Readiness Scale 
Pre-Stage „ , „. Contemplation Preparation Action Maintenance Total * contemplation r 
JZntion 15(50%) 9(30%) 4(13%) 2(7%) 0(0%) 
Women's 
faTmei 16(53%) 6(20%) 3(10%) 3(10%) 2(7%) 
Notification 







Table 4.2 Comparing Gravida with Stages of Readiness Scale 
Gravida Pre- Contemplation Preparation Action Maintenance Total 
contemplation 
Primigravida 7(47%) 4(27%) 
Multigravida 8 (53%) 5 (33%) 
Total 15 (50%) 9 (30%) 
3(20%) 1(7%) 0(0%) 15 
(50%) 
1(7%) 1(7%) 0(0%) 15 
(50%) 
4(13%) 2(7%) 0(0%) 30 
(100%) 
Women have not given any thought to being a cord blood donor 50% of the time 
while 30% are giving some thought to being a cord blood donor weighing the pros and 
cons, 13% are preparing to be a cord blood donor, 7 % have signed consent and not 
spoken with their spouse/partner. Given the distribution of responses, this variable was 
transformed into a dichotomous response of 1) no thought regarding cord blood donation 
and 2) thinking about cord blood donation for further analysis. 
The analysis of the Readiness Scale was adjusted for parity (number of children 
born). Table 4.2 demonstrates that women (86%) with more than one child 
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(multigravidas) were in the Pre-contemplation (53%) and Contemplation (33%) stage 
compared to women (74%) having their first child (primigravida) with 47% in the Pre-
contemplation stage followed by 27% in the Contemplation stage respectively; however 
more of those women who were primigravidas were in the Preparation Stage 20% of the 
time when it is time to decide on cord blood donation. This means they are preparing to 
be a cord blood donor and learning more about their consent options. They are moving 
further along the path to a decision they wish to make for their family regarding donation 
of cord blood. 
Sample Characteristics 
The dataset contains all responses from 30 completed questionnaires from the 35 
which were distributed through volunteer encounters over an 11 month period, August 
2009 to June 2010. This was a response rate of 86%. None of the participants had made a 
decision to collect cord blood at the time of the questionnaire. The demographics of the 
study participants are listed in Table 4.3. 
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Table 4.3 Demographic Characteristics of Study Participants 
Table 4.3a Range 




Gestational Age (weeks) 16-40 24 
Table 4.3 b 
Number of Living Children 
Group 
None 























U u <i i rj,j , HS Diploma 16(53%) 
Highest level of Education ^ ^ H g ^ ^ ^ ^ ? % ) 
Total Household Income/yr. 
Less than $50,000 
Greater than $50,000 
24 (80%) 
6 (20%) 












If not, do you plan to discuss Yes 




Overall, the participants had a minimal education level of a high school education 
(53%) but 14 (47%) had either completed or entered an undergraduate university. Of 
these, 4 (28.5%) entered and completed a postgraduate degree. This may be attributed to 
the severe economic recession in the USA, December 2007 to June 2009. The fact that so 
many women with an advanced age were seen at a community clinic can be attributed to 
this too. San Diego, which is considered a service economy, sustained official 
unemployment rates greater than 10% during this time period (Bureau of Labor Statistics, 
2010) and many of the employed and under employed lost health insurance coverage. 
The participants age ranged from 14 to 45 years of age and gestational age were 
evenly distributed from 16 weeks to 40 weeks. There were two groups that clustered at 23 
weeks and 33 weeks. The majority of the sample (57%) was Hispanic (17) which 
reflected the clinics location as a predominantly Hispanic area in San Diego which has 
grown during the last 20 years. The remaining component reflected the areas diversity: 
23% Caucasian (7), 20% Other (6) of which broke down specifically to: (1) Asian/Pacific 
Islander, (2) Black, (2) Iraqi, and (1) other. Since 2000 there have been economic 
struggles for many families and there an estimate of 2,000 people who used Arabic as 
their main language who migrated to San Diego from Iraq, Jordan, Lebanon, and other 
countries of the Middle East (Coalition, 2010). San Diego is the largest metropolitan area 
west of Detroit, Michigan which houses more than 80,000 members of the Middle 
Eastern population in the last 4 years (Coalition, 2010). However, because my sample 
was small this may not have influenced this at the time but may if future study leads to a 
large sample of the population. 
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The predominant religious groups were 13% Christian (4), Catholic 37% (11) and 
Other as 50% (15). Many included the description for being Caldean and "not Catholic" 
by preferring to be identified as the option of Other. 
Method of payment for prenatal care was predominantly in one of three groups. 
Self-pay 3% (1), Insurance 17% (5), andMedi-Cal (California Medicaid) which was 80% 
or (24). 
*The null hypothesis: "There is no difference in the CBC (Cord Blood Collection) 
Score if one had talked with their obstetrician/CNM OR had not talked with their 
Obstetrician/CNM. AND, if they had not talked, did they plan to talk with them. The 
CBC Score was calculated on a scale of 10 questions. The higher the number out of 10 
the higher the subject scored the more perfect the total score. A t-test for independent 
means compared for two samples that were independent of each other. This method 
{independent) is used to indicate there is no relationship (no matching or pairing) of 
scores from one sample to the other. The selection of individuals for the groups had no 
bearing on the selection of individuals for the control group, the two samples were said to 
be independent. In other words, they were separately and independently drawn from the 
population of participants. 
When measuring the CBC Score with the t-test for independent means on two 
categories of age: the mean for Group 1 (Less than 24 years of age) and Group 2 (24 
years of age or more) the mean for Group 1 {m = 2.26, sd = 2.49) is lower than the mean 
for Group 2 (m = 3.13, sd= 2.94) at the .194 level (/ = -.869, df= 27.2). Because the 
variances were different, a t-test that did not assume equality of variances conducted with 
a confidence interval (CI) = .95. Therefore, there is no significant difference. 
When measuring the CBC Score with the /-test for independent means for two 
categories number of living children: the mean for Group 1 (No living children) and 
Group 2 (1 or more living children) the mean for Group 1 {m = 2.3, sd = 2.46) is lower 
than Group 2 (m = 3.06, sd = 2.9) at the . 143 level (/ = -.733, sd = 27.0). Because the 
variances were different, a t-test that did not assume equality of variance conducted with 
a confidence interval (CI) = .95. Therefore, there is no significant difference. 
When measuring the CBC Score to Race using a One Way ANOVA for more 
than two means, there yields a value of F at 6.423 and the associated probability of .005. 
The difference among the means can be declared significant at the .01 level. For the 
Hispanic group, the mean reported CBC score level was 2.0 {sd =2.4). The mean reported 
CBC Score level for the Caucasian group was 5.4 {sd = 1.9) and the mean reported CBC 
score level for the Other group was 1.5 {sd= 2.3), respectively. The differences among 
the means are statistically significant at the .01 level (F [2,27] = 6.423). 
When measuring the CBC Score with Payment Method using a One WAY 
ANOVA measuring the difference between and among self-pay group, private insurance 
group, and Medi-Cal insurance group there yields F at 3.344 and the associated 
probability of .050. The difference among the payment methods and CBC score is 
significant at the .05 level. For the self-pay, the mean reported CBC Score .000 {sd = 
N/A). The mean reported CBC Score for private insurance was 5.2 (sd- 2.167) and the 
mean for the Medi-Cal insurance and CBC score was 2.3 {sd- 2.5) respectively. The 
difference among and between the means is significant at the .05 level. 
When measuring the CBC Score with the participant answer to: Did you discuss 
CBC with your OB/CNM? If not, do you plan to discuss CBC with your 
Obstetrician/CNM? The following measured: 
The "Sig" for "Levene's Test for Equality of Variances" is .002. Because .002 is 
less than .05, it is not appropriate to assume equality of variances. 
The mean for Group 1 {m = 1.43, sd = 1.83) is significantly lower than the mean 
for Group 2 (m = 3.18, sd= 2.93) at the .05 level (/ = -2.7, df= 25.5). Because the 
variances were significantly different, a / test that did not assume equality of variances 
was conducted. Table 4.4 is the synopses of the data. 
Table 4.4 Response to Cord Blood Collection Survey by Demographic Factors 
Critical 
Test Value P-value 
Age /test -0.869 0.39 NS 
Gestational Age /test -0.081 0.94 NS 
Number of Living Children /test -0.733 0.47 NS 
Marital Status /test 0.054 0.957 NS 
Race ANOVA 6.423 0.01 * 
Religion ANOVA 0.19 0.83 NS 
Highest Level of Education /test 0.24 0.81 NS 
/test -1.69 0.1 NS Total Household 
Income/yr. 
Method of Payment for m m A 3 J 4 4 Q0$ 
Prenatal Care 
Discuss CBC w/OB/CNM /test 1.29 0.2 NS 
If no, do you plan to * „ 
discuss w/OB/CNM? ttGSl ~Zn U U D 
Would it make a difference 
in a decision to CBC if you 










The chance that my baby 
would have a conditionfat A^T^TA ^ ^ ^ n m<r T,™ , . , . , T ^ . , , ANOVA 2.252 0.106 NS birth or in the future) could 
be used 
The chance that a sibling 
who is healthy would AMOVA Ai\~k 
develop a condition that 
could benefit from CBC 
0.01 
For most conditions 
requiring cord blood 
therapy, could a child use ANOVA 0.64 0.64 NS 
cord blood from his/her 
own placenta? 
For most conditions 
requiring cord blood 
therapy, could a child use ANOVA 0.82 0.55 NS 
cord blood from a sibling's 
placenta? 
If your child did need cord 
blood therapy and you did 
not have cord blood stored 
from him/her or a sibling, ANOVA 0.59 0.71 NS 
what is the chance cord 
blood from a public storage 
bank could be used? 
Do San Diego hospitals 
have a system in place 
whereby you could donate ANOVA 0.85 0.48 NS 
the cord blood to a public 
cord bank? 
Age Chi Square x2 3.75 0.053 **(>.05) 
Gestational Age Chi Square x2 9.6 0.002 * (>.001) 
*P= @ the .01 level comparing CBC with Race 
**P= @ the .05 level comparing CBC score with Payment Method 
***P= .014/.012 are unequal and slightly above the .01 level therefore needs to be at the 
.05 level comparing the CBC score and "If one has not discussed CBC with your 
OB/CNM, do you plan to discuss with your OB/CNM? 
70 
Sources of Women's Knowledge 
The main sources of the participant's knowledge came from seeing/reading ads in 
magazines/commercials regarding cord blood storage 53% of the time but only 37% read 
or saw literature related to private banking versus 20% on public banking. Table 4.5 
reflects some other ways like discussing cord blood donation with their obstetrician or 
midwife. This was taken from the Cord Blood Collection Survey Table 2 on page 24 of 
the questionnaire. 
Table 4.5 Sources of Knowledge 
Yes No Total 
Discussed CBC 
w/OB/CNM. 
9 (30%) 21 (70%) 30 (100%) 
If no, do you plan 14 (47%) 
to discuss w/OB/CNM. 





regarding cord blood 
storage. 
11(37%) 19 (63%) 30 (100%) 
Seen/read ads in 
magazines/commercials 16 (53%) 
regarding cord blood 
storage. 
14 (47%) 30 (100%) 
Seen/read literature 
distributed by a public 
cord blood bank 
regarding cord blood 
donation. 
6 (20%) 24(80%) 30 (100%) 
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Women's Belief about Cord Blood Collection, Storage, and Use 
Table 4.6 Women's Beliefs about Cord Blood Collection, Storage, and Use for 
Transplantation 
F2 
Would it make a difference in a decision to store cord blood 
with a private/commercial cord blood bank if you knew that 





The chance that my baby would have a condition (at birth or 
in the future) that could benefit from cord blood during 
his/her first 10 years of life is about: 
1 in 100=4 
1 in 1000=6 
lin 10,000=7 
<1 in 10,000=1 
N/A=12* 
1 in 100=4 
F4 1 in 1000=6 
The chance that a sibling who is now healthy would develop 1 in 10,000=6 
a condition that could benefit from this cord blood is about: <1 in 10,000 =1 
N/A=13* 
F5 
For most conditions requiring cord blood therapy, could a 








For most conditions requiring cord blood therapy, cold a 








If your child did need cord blood therapy and you did not 
have cord blood stored from him/her or a sibling, what is the 









Do San Diego hospitals have a system in place whereby you 






When one assesses and compares the Women's Belief Model about Cord Blood 
Collection, Storage and Use there are numerous beliefs participants shared on the survey. 
The majority 49% (16) answered "NO" followed by 30% (9) as not applicable when 
answering the question, "Would it make any difference in a decision to store cord blood 
with a private/commercial cord blood bank if you knew that your OB would be paid a fee 
to collect the cord blood?" 
When asked, "If there a chance that my baby would have a condition (at birth or 
in the future) that could benefit from cord blood during his/her first 10 years of life...." 
40% answered "not applicable" with the second most frequent answer being 1: 10,000 at 
23%. Another belief expressing the chance that a sibling who is now healthy would 
develop a condition that could benefit from this child's cord blood also answered 43% of 
the time as "not applicable" (13) and the second most frequent answer 1:10,000 (6) or 
20% of the time. 
The belief, "For most conditions requiring cord blood therapy, could a child use 
cord blood from his/her own placenta?" was answered as "usually" (8) 27% of the time 
compared to always (7) 23%, sometimes (6) 20%, rarely (4) 13%, never (0) 0% and "not 
applicable (5) 17% of the time. Another belief, "For most conditions requiring cord blood 
therapy, could a child use cord blood from a sibling's placenta?" answered most 
frequently as sometimes (11) 37% followed by not applicable (8) 27%, usually (6) 20%, 
never 3 (10%), always (1) 3%, and rarely (1) 3% of the time respectively. 
"If your child did need cord blood therapy and you did not have cord blood stored 
from him/her or a sibling, what is the chance cord blood from a public storage bank could 
be used?" most frequently answered rarely (10) 33%, followed in descending order as 
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sometimes (7) 23%, not applicable (5) 17%, always (3), 10%, usually (3) 10%, and 
finally never (2) 7% in that descending order. Another way to look at this would be to 
imply that (13) or 43% had a positive understanding or belief that a public bank could 
help them but (17) or 57% did not believe a public bank could help them. 
The last belief the participants answered was, "Do San Diego hospitals have a 
system in place whereby you could donate the cord blood to a public cord blood bank?", 
and the majority (19) 63% answered they did not know followed by (6) 20% who said 
yes on the survey, and (4) 13% who said no on the survey with (1) 3% answering not 
applicable. This is most likely true as there is clearly not a system set in place to educate 
the public where to obtain public banking in the San Diego municipal area. Even if you 
are highly educated in this group it seemed to still be a barrier for one to find the 
information expressed by one participant when being interviewed and she had a higher 
level of education with a degree as a doctor in philosophy. 
Chapter V 
Discussion of Findings 
The Nation's labor markets were deeply affected by the deteriorating economic 
conditions that began December 2007 and continued for the next two years. Some have 
referred to this period as the "Great Recession" of 2007-2009 (Sum & Khatiwada, 2010). 
The National Bureau of Economic Research, the Nation's arbiter of the beginning and 
ending dates of recessions, has designated the recent recession as having lasted from 
December 2007 to June 2009. 
Because of the recession, 2009 was one of the worst years for poverty in America 
in more than half a century. The total number of Americans living in poverty hit 43.6 
million, the highest level in 51 years and the national poverty rate rose to 14.3 percent 
from 13.2 percent, according to data released late 2010 by the Census Bureau (NCB, 
2010; Huffington, 2010). One in seven Americans is living in poverty at the time of this 
writing per. Mint, the personal finance site, put together an interactive chart of regional 
poverty rates (Mint, 2010) and California's percent of poverty levels range from less than 
10%upto25%-30%. 
Though suburban areas are now home to one-third of America's poor, large cities 
have not been immune to the after math of the recession (Huffington, 2010; Mint, 2010) 
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(NCB, 2010). Residents of cities like San Diego have seen some of the biggest drops in 
personal income in the last year. Crippling poverty rates in many of America's hardest-hit 
regions have been accompanied by several other disturbing trends for the middle class. 
Income inequality hit an all-time high before the recession, according to the University of 
California, Berkley, economist Emmanuel Saez (Huffington, 2010). States, faced with an 
estimated budget shortfall of $380 Billion for 2011 (Huffington, 2010; NCB, 2010; 
Coalition, 2010) have started to cut crucial services and have allowed thousands of 
workers to be jobless. 
Growing layoffs last year caused millions of Americans to lose employee-
provided health insurance, leaving 16.7 % of Americans with no health insurance, the 
highest level since the United States Census started collecting the data in 1987 
(Huffington, 2010). The ranks of discouraged workers and others marginally attached to 
the labor force also had increased during this recession 2007 to 2009. These individuals 
are those who wanted and were available for work and had looked for a job sometime in 
the prior 12 months. They were not counted as unemployed because they had not actively 
searched for work in the past 4 weeks. The number of persons who were marginally 
attached to the labor force increased sharply during the current recession, rising to 2.1 
million in the first quarter of 2009 (Bureau of Labor Statistics, 2009 & 2010). 
The unemployment rate in the San Diego County was 10.2 % in October 2010, 
and below the October 2009 estimate of 10.6%. This compares with an unadjusted 
unemployment rate of 12.0% for California and 9.0 % for the nation during the same 
period (National Bureau of Labor Statistics, 2010). This was during the time the data 
collection took place in San Diego. 
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Patient Profile 
The local clinic has been providing services and programs available to all low-
income residents in the community it serves since 1990 and it celebrated the Twenty Year 
Anniversary in 2010. Many of the patients were immigrants and refugees, many of whom 
were in the country legally and were forced to leave their native countries due to conflict 
or other upheaval as civil war and ethnic cleansing occurred. The clinic placed a high 
value on the support of the family and provided comprehensive programs that strengthen 
both the children and adults. Some patients were second or third generation families from 
the communities they serve. Most were struggling to survive initially when entering the 
United States but are now learning to build their knowledge of the community and its 
resources to become more self-sufficient and they all rely on the clinic not only for health 
care but for their non-medical needs as well. 
One of the local clinics, part of the Central Region of San Diego, is a federally 
designated MUA/MUP-Medically Underserved Area/Medically Underserved Population. 
The primary service area has a population of 199,230 which is a small part of a larger 
extended area that includes the entire Central Region of San Diego County with a 
population of approximately 488,205. The community clinics data characteristics are as 
follows: 64% are women (83% of those are of childbearing age). Ninety-six percent 
(96%) are non-white and 80% say they prefer to be served in a language other than 
English. An astounding 98% of them are below the Federal definition of poverty (double 
that of all of San Diego County, the state of California and the United States as a whole). 
The vast majority (92%) are either uninsured or rely on public insurance programs for 
partial coverage (La Maestra Community Health Centers, 2007). The location in the 
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community serves as a mesh of inner city challenges of poverty, unemployment, and poor 
access to health care or social services. Linguistic and cultural barriers compound these 
problems. The need for translators to be provided to health care workers caring for this 
population has been challenged as there are over 37 separate census tracts served by this 
overburden facility on Fairmount Avenue (La Maestra Community Health Centers, 
2007). There are no "County Hospitals" in San Diego. This region of the city has a 
19.22% poverty rate (Mint, 2010; Bureau of Labor Statistics, 2010; La Maestra 
Community Health Centers, 2007), highest teen birth rate, lowest prenatal care utilization 
rates, lowest health insurance coverage rates, and highest rate of reported child abuse. 
El Cajon was the second area of data collection in the East San Diego County. It 
is a more rural desert setting and experiences similar problems to those of City Heights. 
In El Cajon, the majority of the population is Latino although "official" census numbers 
report only 26%. This was witnessed by this researcher working as a nurse practitioner 
and midwife over the last two to two and one-half years when she wimessed the majority 
of the patients coming to the clinic suddenly changed from Latino to populations from 
Iraq and other Middle East Countries with Arabic as their main language. Because of the 
high cost of housing in coastal areas, there is a migration of middle income, working 
people buying homes in El Cajon and commuting west. From outward appearances 
household incomes seem to be increasing but this development masks the fact that there 
is still high local unemployment, underemployment, and poverty. Many Hispanic 
refugees and Chaldean immigrants, who escaped from Iraq, live in El Cajon and struggle 
with linguistic and cultural barriers that continue to exist. There are 29 different census 
tracts with a total population of 118,902 (according to the 2002 census). All of the East 
Region of San Diego County has a population of approximately 446,750. 
In both of the clinics there is a high use of translators/interpreters due to the 
limited English proficient (LEP) skills of many patients. An estimated 50 million people 
in the United States do not speak the same language as their healthcare provider, and 23 
million are considered LEP (Rousos, Mueller, Hill, Sala, Hovell, & Villarreal, 2010). 
This was particularly apparent with the women who present with Arabic as their main 
language. They preferred female translators over male translators a vast majority of the 
time. The attention to the role of gender during interpreted medical visits is important to 
improving health care and health for persons with LEP. At both climes it is a common 
practice to minimize use of family members or friends for translation due to 
confidentiality and use bilingual staff members or professional interpreters. This was 
mandated by Federal Civil Rights legislation since 1964 where language assistance 
services became available free of charge for all LEP patients at all points of health care 
(Chen, Youdelmanm, & Brooks, 2007). Although the research is very limited in the use 
of gender with LEP patients it is hopeful that the influence of the interpreter on provider-
patient communication is likely to reduce the disparities in the medical outcomes across 
chronic and acute illnesses (Rousos, Mueller, Hill, Sala, Hovell, & Villarreal, 2010). 
Cord blood is a noncontroversial source of stem cells, yet experts estimate that 
99% (Rochman, 2010), of this potentially lifesaving resource gets thrown away in the 
postpartum period. One may believe from this study that it is due to so many barriers 
present to them around concerns of communication and the options of how to ascertain 
the information. Unlike the stem cells in human embryos, which can morph into any kind 
of cell in the body, the stem cells in cord blood have their futures largely mapped out 
(Powell, Hingorani, & Kolb, 2009) as blood, brain, liver or heart muscle cells for 
example. But researchers have shown that cord blood cells can be reprogrammed, and 
over the next decade, doctors hope to adapt these cells to treat heart attacks, strokes, 
diabetes and maybe neurodegenerative diseases too. An interview by Bonnie Rochman 
with Dr. Joanne Kurtzberg, director of the Carolinas Cord Blood Bank at Duke 
University (Rochman, 2010) she states: "Cord blood is already being used in therapy 
regimens for patients with cancer, sickle-cell anemia, immunodeficiency, marrow failure 
and genetic diseases that call for transplants". As their due date creeps closer, many 
pregnant women pack a "go bag" for the hospital: toothbrush, personal music selections 
to listen when in labor, cute outfit to dress baby in when coming home. Over the last few 
years savvy mothers-to-be have started tucking in one more important item: a kit to 
collect and donate the blood in their babies' umbilical cord. This is only accessible for the 
woman who can afford such a high price of $2,000-$3,000 for the kit to complete the 
initial processing and approximately $125 to $250 per year after that to store cord blood 
that can be used only by the donor's family when donating to a private bank. Or, if it is a 
public bank, by contrast, one can make their contents available to anyone who is a close 
enough match at no cost or fee. 
The question this researcher posed to the marginalized population in this study: 
Do women know that this form of stem cell therapy is available through cord blood 
collection at the birth of their infant? And, if they do, can they have a choice of cord 
blood storage through knowing the difference between a private or public bank living in 
San Diego County? Of note was 70% of the women had not discussed cord blood 
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donation with their provider and of those, 47% planned to discuss it with their OB/CNM. 
This brings this researcher to the conclusion they were curious and had a plan in mind. At 
what level of readiness where they at the time of the survey? Women's intention was in 
the Pre-contemplation Stage 50% and Contemplation Stage 30% of the time. That means 
80% of the population studied were ready to act on the information they had learned from 
at the time of the survey. Women's Spouse/Partner Notification pre-dominantly in the 
Pre-contemplation Stage 53% of the time followed by the Contemplation Stage 20% of 
the time. 
When one compares gravida with stages of readiness scale one may speculate that 
the more pregnancies one has the more likely they are to be more in the stages of 
readiness such as preparation and action. What data illustrated 7 (47%) of Primigravida 
and 8 (53%) of Multigravida group were in the Pre-contemplation Stage and the rest were 
in the Contemplation 4 (27%0, 5 (33%), Preparation Stage 3 (20%), 1 (7%) and Action 
Stage 1 (7%), 1 (7 %) respectively between Primigravida and Multigravidas. Their 
sources of knowledge came from seeing/reading ads in magazines/commercials regarding 
cord blood storage 53% of the time but only 37% read or saw literature related to private 
banking versus public banking 20% of the time respectively. 
When looking and comparing the women's beliefs about Cord Blood Collection, 
Storage, and Use most of the women answered "not applicable" to their belief questions 
because I believe they truly did not know. They answered "usually" for most conditions 
requiring cord blood therapy when the child could use his/her own cord blood from the 
placenta. The likelihood of this occurring has been proven in the scientific journals 
(American Academy of Pediatrics, 2007, pp. 165-170) and range from less than 1 in 1,000 
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to more than 1 in 200,000 (Johnson, 1997). No accurate estimates exist of the likelihood 
of children to need their own stored cord blood stem cells in the future (American 
Academy of Pediatrics, 2007, pp. 165-170). They also answered "sometimes" cord blood 
can be used from their siblings placenta, which is more often the case. There is only a 
25% chance for identifying a full HLA match in a sibling donor (Karanes, Confer, 
Walker, Askren, & Keller, 2003; Wagner, 1996). The question related to the belief: "If 
your child did need cord blood therapy and you did not have cord blood stored from 
him/her or a sibling, what is the chance cord blood from a public storage bank could be 
used", was answered "rarely" when the literature clearly states there is a high probability 
in a public bank this can be found. There are more than seven million potential unrelated 
volunteer adult donors registered in the National Marrow Donor Program registry 
(Karanes, Confer, Walker, Askren, & Keller, 2003) and there are many patients unable to 
find a fully matched donor, which diminishes access to transplantation therapy. Nonwhite 
patients have a lower chance of identifying a fully matched unrelated adult donor because 
of genetic heterogeneity and lack of non-white donors. However, over the last decade, 
unrelated-donor, banked umbilical cord blood has been shown to contain sufficient 
numbers of stem cells for successful transplantation between unrelated, partially HLS-
mismatched individuals (Kurtzberg, Laughlin, Graham, et al., 1996; Rubinstein, Carrier, 
& Scaradavou, 1998; Rocha, Wagner, Sobocinski, et al., 2000; Gluckman, Broxmeyer, 
Auerbach, et al., 1989; Migliaccio, Adamson, Stevens, Dobrila, Carrier, & Rubenstein, 
2000). This means with the advances in the clinical practice of cord blood 
transplantation, most patients unable to find a fully matched adult donor can identify a 
partially matched cord blood donor. The final question: "Do San Diego hospitals have a 
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system in place whereby you could donate the cord blood to a public cord blood bank?" 
was answered by most of the participants as "don't know" and they don't know because 
there is little advertising in this area. The area is predominantly taken over by the for-
profit cord blood banks. They learned that San Diego does not offer public banking 
because they have no such bank in this geographic area based on the interviews done on 
11 of the participants whom were interviewed. 
Shared decision making should be the commonly used process, requiring shared 
information among relevant care providers and a willingness and capability to 
communicate effectively with parents. This process also suggests the need for outcome 
data. Such data should be relevant to the population seeking care at a given institution. 
Relying on national or other reported regional or institutional data from outside a 
particular practice setting is not always valid, because data from different practice 
settings likely are neither constituted nor controlled in the same fashion. The provision of 
care, which is decided by local clinical and population data and the determination of best 
interests, or what can be viewed as effective, beneficial, and appropriate care versus 
ineffective, burdensome or inappropriate care, demand the availability of data from 
which to make these determinations with parents (Carter, 2009). Until such data are 
available, healthcare professionals should be frank in recognizing and communicating 
some uncertainty in their decisional process with parents. Conversely, although objective 
outcome data are important, for any given baby and their parents, the chance of a certain 
outcome is either 0 or 100% in their minds. Thus, discussions of relative risks, while 
useful for healthcare professionals may not be particularly helpful when discussing 
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treatment options, risks, and benefits with parents and other family members (Carter, 
2009). 
Why does one even care or have concern about how one gets hematopoietic stem 
cells transplanted from cord blood or sometimes called placental blood versus bone 
marrow? 
Stem cells are self-renewing cells defined by two properties: (1) they can proliferate to 
make differentiated cell types of a tissue in vivo, and, once developed, (2) they can 
continue to self-renew for the lifetime of the organism. Presently the only stem cell of 
clinical relevance is the hematopoietic stem cell, which can reconstitute the blood system 
after bone marrow transplantation (Nussabaum, Mclnnes, Willard, & & Boerkoel, 2001). 
Although bone marrow has long been the major source of transplantable 
hematopoietic stem cells and progenitor cells, the discovery that placental blood OR cord 
blood represents a rich source of hematopoietic stem cells is beginning to make a 
substantial impact on the treatment of malignancy and genetic diseases. 
The use of cord blood has three great advantages over bone marrow as a source of 
hematopoietic stem cells. First, recipients are more tolerant with incompatible cord blood 
than of other allogeneic (other) donor cells. Thus, engraftment occurs even if as many as 
three HLA antigens are mismatched between the donor and the recipient. Second, the 
wide availability of cord blood, together with the increased tolerance of incompatible 
donor cells, greatly expands the number of potential donors for any recipient. The latter 
feature is of particular significance to patients from minority ethnic groups, for whom the 
pool of potential donors is relatively small. Third, the risk of graft-versus-host disease is 
substantially reduced using cord blood cells as the donor source. It is likely that the 
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isolation and characterization of stem cells from other tissues, including nervous system, 
will eventually make cell replacement feasible in a wide variety of malignancies and 
genetic diseases; (Arora et al., 2009; Hansen et al, 1998; Moore, 2010; Gutman et al., 
2009; Kataoka et al., 2008; Koh, 2004). 
Nursing Implications 
The American Medical Association and the American Academy of Pediatrics 
recommends public banking over private, favoring private banking only when there is 
already an affected family member or a disease in the family that would benefit from a 
transplant. Many consumer cord blood banking organizations do not support one type of 
banking over another but recommend that parents be informed of the pros and cons of the 
various options (Besser, Schwartz, Romo, & Salahi, 2010). 
According to Frances Verter, founder and director of the nonprofit organization, 
Parent's Guide to Cord Blood Foundation, the overall benefits outweigh the chance it 
may never be used. And, because there are only 17 public banks in the U.S. that tend to 
collect units from nearby hospitals, many families may not be in an area where public 
bank donation is as accessible. That makes it more difficult for many parents to 
understand their options when it comes to choosing between public and private banking. 
There is a problem in that there are a limited number of places that accept donations. The 
downside is that lots of parents want to donate, but it requires money to process the 
donation. There's a certain infrastructure involved that not a lot of centers have in place. 
Furthermore in the report it goes on to say, according to Chris Ober, co-founder of Save 
the Cord Foundation, besides the limited number of public banks available for parents to 
choose, it is often difficult to distinguish between the various options that individual 
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private companies offer. Everything looks great on the Internet, but there are great 
differences between all of the private banks. One really needs to do your homework to 
make sure the bank you choose is right for you (Besser, Schwartz, Romo, & Salahi, 
2010). 
Cord blood donation should be discouraged when cord blood stored in a bank is to 
be directed for later personal or family use, because most conditions that might be helped 
by cord blood stem cells already exist in the infant's cord blood (i.e., premalignant 
changes in stem cells). Another way to explain this to parents is the potential for children 
needing their own stored cord blood stem cells in the future for autologous (self) use is 
controversial at this time (Johnson, 1997). There is also not any evidence of the safety or 
effectiveness of autologous cord blood stem cell transplant for the treatment of malignant 
neoplasms. There is evidence demonstrating the presence of DNA mutations in cord 
blood obtained from children who eventually develop leukemia (Rowly, 1998). 
Therefore, autologous cord blood transplantation might even be contraindicated in the 
treatment of a child who develops leukemia. Care providers should be aware of the 
unsubstantial claims of private cord blood banks made to future parents that promise to 
"insure" infants or family members against serious illnesses in the future by use of the 
stem cells contained in cord blood. Although not standard of care, directed cord blood 
banking should be encouraged when there is knowledge of a full sibling in the family 
with a medical condition (malignant or genetic) that could potentially benefit from cord 
blood transplantation. 
Cord blood donation should be encouraged when the cord blood is stored in a 
bank for public use. Parents should be informed that chromosomal abnormalities and 
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infectious disease testing is performed on the cord blood and that if abnormalities are 
identified, they notified. Parents need to know the cord blood banked in a public program 
may not be accessible for future private use. 
Private storage of cord blood as "biological insurance" should be discouraged. 
Cord blood banks should comply with national accreditation standards developed by the 
Foundation for the Accreditation of Cellular Therapy (FACT), the US Food and Drug 
Administration (FDA), the Federal Trade Commission, and similar state agencies. 
The following recommendations are suggested to minimize any barriers to parents 
through institutions or organizations (private or public) involved with cord blood 
banking: 
Cord blood banking recruitment practices should be developed with an awareness 
of the possible emotional vulnerability of pregnant women, their families and friends. 
Efforts should be made to minimize the effect of this vulnerability on cord blood banking 
decisions such as discussions with providers well in advance of active labor. 
Accurate information about the potential benefits and limitations of allogeneic 
and autologous cord blood banking and transplantation should be provided. Parents need 
to be informed that autologous cord blood would not be used as a stem cell source if the 
donor developed leukemia later in life. Parents need to know that cord blood is a tissue 
source not proven to be used as yet in regenerative medical purposes but the advancement 
of the science is continuing at this time. 
Policy should be developed by the cord blood banks regarding disclosing to the 
parents any abnormal finding in the harvested blood. 
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Specific permission for maintaining demographic medical information should be 
obtained, and the potential risks of breaches of confidentiality should be disclosed. 
Written consent should be obtained before onset of active labor. 
If blood bank is conducting research, an institutional review board must review 
and approve recruitment strategies and consent forms. 
Cord blood collection should not be performed in complicated deliveries. The 
cord blood stem cell collection program should not alter routine practice for the timing of 
umbilical cord clamping. 
All cord blood banking programs should comply with FACT or equivalent 
accreditation standards. 
Other professionals and physicians who recruit pregnant women and their families 
for for-profit placental cord blood stem cell banking should disclose any financial interest 
or other potential conflict of interest they have in the procedure to their patients. 
Professionals affiliated with institutions or organizations that promote for-profit 
placental blood stem cell banking should make annual financial-disclosure and potential-
conflicts-of-interest statements to an appropriate institutional review committee that 
possesses oversight authority. 
Targeted efforts should be made to recruit underserved minorities (black, 
Hispanic, American Indian/Alaska Native individuals) in public cord blood banking 
programs to extend to them potential treatments afforded other segments of society. 
Conclusion 
This was a mixed method of quantitative and a small qualitative research piece. 
The qualitative method was limited due to financial limitations and time limitations. 
Thirty of the surveys were entered into this research for analysis with one third of them, 
eleven, sharing an additional interview with the researcher centered on the question of 
cord blood donation. Two additional participants were not used as they changed their 
decision to participate. The respondents had a poor overall understanding of cord blood 
banking. There were multiple barriers to accurate information between public and private 
banking. Even though the majority of the respondents were Hispanic with a high school 
education and some even had completed two years of college, a respondent who had a 
doctorate degree in philosophy also had a difficult understanding between public and 
private cord blood banking and difficulty locating where to access a public cord blood 
bank. Part of the puzzle is also accessing banks that have proper funding because 
allocation of funding to public banks is limited. The aim of the survey was to conduct it 
with most of the respondents in the 22 to 24th week of pregnancy but some were 
conducted later in the pregnancy at approximately 32 to 36th week of pregnancy. It is 
unlikely that more women would have made a decision regarding cord blood storage if 
they had been surveyed later in pregnancy because the Cord Blood Collection (CBC) 
Survey and the Stages of Readiness Scale for Decision Making reflected the knowledge 
they had during their pregnancy at the time. Moreover, despite the high proportion of 
women in this survey who were in the stages of readiness, they desired to leam more and 
did want to donate cord blood. Many in this marginalized population did not have an 
opportunity to donate cord blood as they were not able to afford the financial burden of 
the cost through private cord blood donation. Along with this, there was not a local public 
cord blood bank in the geographic area of San Diego during the time of this study 2009-
2011. 
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Future research should focus on strategies to educate women earlier in the 
pregnancy or during the pre-conceptual period so they are prepared to make a truly 
informed decision at the appropriate time. The researcher was still amazed in an 
industrialized country such as the United States how easy one can organize their choices 
in life to donate organs for end of life on their driver's license, which they are required to 
carry on their person, enter options for possible transplant donation before ones demise, 
and even arranging for breast milk banking and donation without too many barriers but 
the steps to take to complete a contribution to a public cord blood bank seems to continue 
to be a barrier throughout this advanced technology. One may see the change coming 
slowly but only from the consumer driven based decision to request public cord blood 
banking from their healthcare provider, their healthcare provider learning how to 
contribute through the process of public cord blood collection, and seeking the avenues 
for public donation can this option possibly advance to make this less cumbersome for 
the public at large. The future of stem cell research will depend on this and advance the 
technology of cord blood use in treating multiple diseases. 
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Appendix A 
Stem Cell Sources 






• Non-controversial and supported by 
legislation 
• More cells may be available per 
collection 
• Mows for future collections 
• Demonstrates some degree of 
developmental plasticity (ability to 
be molded) 
• Indicated as therapy for numerous 
human diseases and used in 
transplant for more than 40 years 
• Non-controversial, readily 
available, and supported by 
legislation 
• Highly proliferative and improves 
the rate of self-renewal 
• Increased developmental plasticity, 
allowing differentiation into 
multiple cell types 
• Tolerant of 2 or more HLA 
mismatches due to immunologic 
immaturity 
• Indicated as therapy for numerous 
human diseases (75) and used in 
transplant for more than 15 years 
• Decreased rates of GVHD (graft 
vs. host disease) 
• Young cells with longer telomeres 
• Highly proliferative improving the 
rate of self-renewal 
• Increased developmental plasticity, 
enabling differentiation into 
multiple cell types 
• Involved in research that furthers 
our understanding of cellular 
development 
• Young cells with longer telomeres 
DISADVANTAGES 
• Less proliferative than younger cell 
types 
• Tolerant of only 1 or fewer HLA 
antigen mismatches 
• Provides older cells with shorter 
telemeres 
• Invasive collection procedure that 
poses some risk to the donor 
• Registries are subject to donor 
attrition 
• Increased rate of GVHD (graft vs. 
host disease) compared with use of 
younger cells 
• One-time collection, at birth only 
• Cell count limited to quantity 
available at birth, until expansion 
technologies are approved for use in 
patients 
• Delay engraftment when samples 
with decreased cell dose are used 
• Controversial and heavily restricted, 
even for research purposes 
• No validation in human patients 
• Difficult to regulate and prone to 
teratoma formation (tumors) 
(Young, 2006) 
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Appendix B 
Diseases Potentially Treatable with Umbilical Cord Blood Stem Cell Transplants 
112 
Diseases potentially treatable with umbilical cord blood stem cell transplants 
Acute leukemias 
Acute biphenotypic leukemia 
Acute lymphoblastic leukemia 
Acute myelogenous leukemia 
Acute undifferentiated leukemia 
Chronic leukemias 
Chronic lymphocytic leukemia 
Chronic myetogenous leukemia 








Refectory anemia with excess 
blasts 








































Beta thalassemia major 
Pure redceD aplasia 
Sickle cell disease 






Bare lymphocyte syndrome 
Common variable immunodeficiency 
DiGeorge syndrome 
Kostmann syndrome 
Leukocyte adhesion deficiency 
Omenris syndrome 
SCID with adenosine deaminase 
deficiency 
Severe combined immunodefiaency 
disease(SCID) 
Wiskott-Aldrich syndrome 
X-linked Lymphoprolflerative disorder 
113 















Renal cell carcinoma 








Plasma cell disorders 
Multiple myeloma 
Plasma cell leukemia 
WakJenstrorris macroglobulinemia 
SCID = severe combined immunodeficiency disease 
(Adapted from Moise, 2005; Perlow, 2002) 
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Appendix C 
Stages of Change Model 
stable behaviour 
contemplation I relapse 
pre-contemplation. 
Stages of Change Model 
Figure 1: Stages of Change Model 
Prochaska, J.O. & DiClemente, C.C. (1982). Transtheoretical therapy toward a more integrative 
model of change. Psychotherapy: Theory, Research and Practice, 19 (3), 276-287, 
(Prochaska & DiClemente, 1982). 
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Appendix D 
Asian Cord Blood Inventory of 
Umbilical Cord Blood Use and Umbilical Cord Blood Transplants 
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Regenerative Medicine Activities in Low- and Middle-Income Countries 
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Milestones in Umbilical Cord Blood Banking and Transplantation 
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Discussions between H. Broxmeyer and T. 
Boyse about the potential clinical use of 
UCB as a source of hemotopoietic stem 
cells. 
E. Gluckman and colleagues in Paris 
perform first related donor UCB transplant 
for a child with Fanconi anemia. 
R. Harris and colleagues in Cincinnati, 
Ohio, perform the first related donor UCB 
transplant in the US. 
J. Kurtzberg and colleagues at Duke 
University in Durham, North Carolina, 
perform the first unrelated donor UCB 
transplant. 
P. Rubenstein and colleagues at the New 
York Blood Center establish the first 
public, unrelated donor cord blood bank. 
J. Wagner and colleagues report in The 
Lancet the results of related and unrelated 
donor UCB transplants. 
The National Heart, Lung and Blood 
Institute of the National Institutes of Health 
award funding for UCB banks and 
transplant centers to conduct a national 
safety and efficacy trial. 
J. Kurtzberg and colleagues report in the 
New England Journal of Medicine the first 
large series of unrelated donor UCB 
transplants. 
P. Rubenstein and colleagues report in the 
New England Journal of Medicine results 
from 562 unrelated donor UCB transplants 
performed worldwide. 
Cryo-cell and Gen-cell first initiation to 
collect placentas for placental stem cell 
research by Gen-cell and Cryo-cell. 
UCB = Umbilical cord blood 
(Smith, 2000; Cryo-cell, 2006) 
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Appendix G 
Financial Report of Umbilical Cord Blood Banking 
Private versus Public in the United States and Europe 
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BANKING: Private versus Public Banking in the United States and Europe 
• Private donation is predominate; it's often called Family Banking as it may be given 
to a related member of that child. 
• Recruitment from OB clinics, via the Internet & promotional material 
• Inducements-incentives to recruiters with commission on every "sale" 
• Parents in form of club membership for the child which gives entry to a 
sweepstakes providing access to four $10,000 college scholarships/yr 





Process if needed 
Private or Family 
$1,100 to $1,975 




Free Processing fee $1,000 
which the bank incurs 
$l,000/unit 
May charge the insurance 
company 
Can be $15,000-$35,000/unit 
May charge the insurance 
company 
• Public donation is predominate; parents donate their child's cord blood for 
unrelated use. 
• Recruit from OB clinics but within a local or regional network; difficult to donate if they 
do not come from within the geographic area of public banking 
• Ensure wide diversity of ethnic groups 
• Sources of funding-Red Cross, Jose Cameras Foundation, charitable foundations as 
ADISCO (Italy), Commonwealth state and territory government research and 




Processing if needed 
Private 
€175 ($150) 
Includes cost of kit and cost 
of initial processing 
€175 ($150) 
Includes cost of kit and cost 





Charge if have insurance 
Otherwise no charge 
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Appendix H 
Staging Algorithm for Cord Blood Donation Intention with 
Readiness of Change Model 








Cord Blood Donation 
Intention 
I have not given any 
thought to being a cord 
blood donor. 
I'm giving some though to 
being a cord blood donor 
and weighing the pros and 
cons. 
I'm preparing to be a cord 
blood donor, learning more 
about consent options. 
I have signed a cord blood 
consent, but I have not yet 
talked with my spouse 
about this. 
I have signed a cord blood 
consent, and I have talked 
with my spouse about this. 
Spouse Notification 
I have not given any 
thought to discussing with 
my spouse how I feel about 
cord blood donation. 
I'm giving some thought to 
discussing with my spouse 
how I feel about cord blood 
donation. 
I'm preparing to talk with 
my spouse about how I feel 
about cord blood donation. 
I have talked with my 
spouse about how I feel 
about cord blood donation. 
I have talked with my 
spouse about how I feel 
about cord blood donation, 
and about how he feels 
about cord blood donation. 
Adapted from Prochaska et al. (Prochaska, Velicer, & Rossi, 1994; Quinn, Alexander, 





Table 1. Demographic characteristics of study participants 
Overall % Donating to Donating to 















Marital Status Married 
Single 
NA 
Race American Indian/ Alaskan Native 




























less than $50,000/year 
$50,000-$ 100,000/year 
greater than $100,001 up to $150,000/year 
greater than $150,001 up to $200,000/year 
greater than $200,001 up to $250,000/year 
greater than $250,001 up to $300,000/year 
greater than $300,001 up to $400,000/year 
greater than $400,001 up to $500,000/year 




Table 2. Patients' sources of knowledge about cord blood donation 
Yes/No Donate to Private Bank % Donate to Public Bank % 
Discussed cord blood collection with obstetrician. 
If did not discuss with obstetrician, plan on discussing cord blood collection with obstetrician. 
Seen/read kterature distributed by private/commercial cord blood collection companies regarding 
cord blood storage. 
Seen/read ads in magazines/commercials regarding cord blood storage. Seen/read literature 
distributed by a public cord blood bank regarding cord blood donation. 
Table 3. Patients' beliefs about cord blood collection, storage and use. 
Overall % Donate to Private Bank % Donate to Public Bank % 
Would it make a difference in a decision to store cord blood with a private/commercial cord blood 




The chance that my baby would have a condition (at birth or in the future) that could benefit from 
cord blood during his/her first 10 years of life is about: 
1 in 100 
1 in 1000 
1 in 10,000 
<1 in 10,000 
N/A 
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The chance that a sibling who is now healthy would develop a condition that could benefit from 
this cord blood is about: 
1 in 100 
1 in 1000 
1 in 10,000 
<1 in 10,000 
N/A 
For most conditions requiring cord blood therapy, could a child use cord blood from 














If your child did need cord blood therapy and you did not have cord blood stored from him/her 








Table 4 Patients' knowledge about current incfieatiomfOTCoribloodtansr̂  
Overall % Donate to Private Bank % Donate to Public Bank % 




























































Sources of Knowledge, Beliefs, Knowledge on Transplants to Stages of Readiness Scale 
135 
Table 5. Sources of Knowledge, Beliefs, Knowledge on Transplants to 

























Interview Guideline: Cord Blood Donation 
1. How did you hear or see information about cord blood donation? 
2. When did you receive information about cord blood donation? 
3. Tell me what your understanding of the process in cord blood donation is and how it occurs? 
4. Have you discussed cord blood donation with your obstetrician, PCP, or CNM yet? Do 
you plan to do so? 
5. Would it make a difference in a decision to store cord blood with rmvate/commercial cord 
blood bank if you knew that your obstetrician, PCP, or CNM would be paid a fee to 
collect the cord blood? 
6. What is your understanding regarding a chance that your baby would have a condition (at 
birth or in the future) that could benefit from cord blood during his first 10 years of life? 
7. If you chose to store cord blood in a private/commercial bank what would be your primary 
reason? 
8. If you chose to store cord blood in a public bank what would be your primary reason? 
9. Tell me how you feel about San Diego hospitals having a system in place whereby you 
could donate cord blood to a public cord blood bank at the birth of your child? 
10. Do you have anyfnoughts about your future beliefs regarding stem cell research through 





Cord Blood Donation Information and Assent Form 
Irene Carr, RN, MSN CFNP, CNM, doctoral candidate and student, University of San 
Diego is mterviewing volunteers as part of her research study. The purpose of the study: 
• To develop better understanding of public and private cord blood 
donation, storage and use. 
• To obtain community members perspectives on the option of cord blood 
donation in the San Diego County. 
• To obtain input from a broad segment of the population 
Participants, couples and individuals, interested in the phenomenon of how they are making 
decisions to collect cord blood at the birth of their child and what is their understanding and belief 
about this process will be addressed in a questionnaire followed by an interview. Those willing to 
express their views on stem cell research from cord blood collection and how they make a decision 
to use private or public banking will be addressed. You will be asked other characteristics 
relevant to the study. 
The interview will involve one interview that asks questions about your pregnancy and how 
you heard about cord blood collection. The interview will last about 60-90 minutes and also will 
include some questions about you, such as your age, gender, gestational age, number of children you 
have birfhed, rac^ethnicity, religion, highest level of education completed, financial status, and 
method of payment for prenatal care. The interview will take place at a time and place convenient 
for you. Participation is entirely voluntary and you can refuse to answer any question and/or quit at any 
time. Should you choose to quit, no one will be upset with you and your information will be 
destroyed right away. 
The information you give will be analyzed in a manner that protects your identity. That means 
that a code number will be used and that your real name will not appear on any of the materials 
used 
There may be a risk that participating in the interview may make you feel tired. Remember, 
you can stop the interview at any time you feel tired or for any other reason The other risk may be 
discourse in your decision to donate or not donate cord blood. 
The benefit to participating will be in knowing you helped doctoral nursing students 
leam how to ensure every pregnant woman the opportunity to make a well informed 
decision about cord blood donation/banking. 
If you have any questions about this interview, please contact Dr. Mary-Rose Mueller at 
the University of San Diego, 619-260-4562. 
I have read and understand this form, and agree to the reseaixfo purposes it describes to me. 
This form is given to me for my records. 





CORD BLOOD at Birth 
SURVEY 
DECISION to DONATE 
Amanda Louise Enisley 
Nurse researcher is actively seeking women during their 
pregnancy to volunteer for a survey regarding their 
knowledge on cord blood banking. Takes 15 minutes. 
Please contact Irene Carr, MSN, FNP-BC, CNM at 
619-823-5650 OR 619-262-5925 for further information. 
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Appendix N 
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Appendix O 
Answers to Interview Questions 
146 
Interview Questions on Cord Blood Donation 
How did you hear or see information about blood donation? 
1. TV commercial and internet. 
2. TV and @ UCSD. "1 had to make a choice between circumcision and 
donating cord blood." 
3. My PCP asked me. 
4. TV 
5. My doctor. 
6. Television and OB, PCP. 
7. From my doctors office. 
8. Dr Irene Carr. 
9. From my midwife. 
10. OB family Nurse Practitioner... she gave her handout. 












you receive information about cord blood donation? 
Not applicable. 
Papers w/last pregnancy 5 yrs ago. 
Today!! 
I have not information. 
I don't know. 




10. At 12 weeks gestation. 
11 . Continuously 
Tell me what your understanding of the process in cord blood donation is and how it 
occurs? 
1. You give consent for hospital or Party to take donation. 
2. Some hospitals have kits kept there if you decide to use them. UCSD has kits. 
I did not get kits. 
3. I would like to do this. 
4. I don't have a lot of understanding because I really don't know much about it. 
5. I don't know. 
6. Hospital collects it, sends it to bank; if baby has leukemia in future you can 
use the blood from the bank. 
7. I don't know. 
8. "No answer" 
9. I need more information regarding Cord Blood Donation to decide what my 
future choices. 
10. Private versus Public. 
11. Not very much. 
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Have you discussed cord blood donation with your obstetrician, PCP, CNM yet? Do you 
plan to do so? 
1. YES. 
2. Yes, as sickle cell is in my family members. 
3. Yes. 
4. No, haven't discussed it with my obstetrician. Maybe. 
5. 1 have not. I don't know. 
6. Yes. 
7. No, But I plan to do so. 
8. 1 need to talk with my husband. 
9. I do not know much about it at this time. 
10. Yes. 
11. No. But maybe I am ready now. (this participant is 39 weeks GA). 
Would it make a difference in a decision to store cord blood with private/commercial 
cord blood bank if you knew that your obstetrician, PCP, CNM would be paid a fee to 




















Yes, it depends. 
No difference. 
NO! 
What is your understanding regarding a chance that your baby would have a condition (at 
birth or in the future) that could benefit from cord blood during his first 10 years of life? 
1. Little or no understanding. 
2. Yes in the next ten years sickle cell may surface in my kids. 
3. Don't know. 
4. Don't know. 
5. I don't know. I do not have any children yet. 
6. I understand it can be used if your child has leukemia. 
7. Pretty good understanding. 
8. "No answer." 
9. "No answer." 
10. No idea of rates and condition. 
11. I do not know what the probabilities are??? 
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If you chose to store cord blood in a private/commercial bank what would be your 
primary reason? 
1. It would be beneficial and free to do so. 
2. For the health of my kids. 
3. Don't know. 
4. To benefit my child. 
5. In case it is ever needed for my child. 
6. For the health of my baby. 
7. For private/family use. 
8. For the future if my daughter would need it. 
9. Is it a safe procedure? 
10. Just to have it available, if one needs it. 
11. To help my son if he had a disease. 
If you chose to store cord blood in a public bank what would be your primary reason? 
1. It would be free to do so, and it would be available to my child if needed, 
as well as others. 
2. It's free. Everyone can use it. Many don't have money to pay for private 
donation. 
3. Don't know. 
4. To benefit my child. 
5. In case it is ever needed. 
6. For the health of my baby. 
7. They do not offer this in San Diego. 
8. Some babies may need this. 
9. Is it a safe procedure. 
10. The low cost. 
11. I am not sure what the difference between storing privately and publically. 
Tell me how you feel about San Diego hospitals having a system in place whereby you 
could donate cord blood to a public cord blood bank at the birth of your child? 
1. I think it would be a great ideal if it were free for personal and public use. 
Yet, 1 would be against it if it was to profit financially to companies or 
misused. 
2. Yes that would be great but they don't have one right now. 
3. I think it's good. 
4. Don't know. 
5. I'm neutral about it. 
6. Good it can help anyone because you don't know at the time of the 
birth. 
7. No thoughts. 
8. "No answer." 
9. If it is a safe procedure I would not mind. 
10. I would use it if it was available. 
11. That would be great if this was available. 
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Do you have any thoughts about your future beliefs regarding stem cell research through 
cord blood collection? 
1. I like the idea of stem cell research to help people and cure diseases—Yet, I 
do not approve of companies profiting off of donated cord blood or misuse or 
sale of such discoveries. 
2. They should do it. 
3. No. 
4. No. 
5. No, I do not. 
6. Yes, continue to do the research and educate parents on their options. 
7. I think it is a great idea. 
8. "No answer." 
9. I will look into it and research about it. 
10.1 am learning; and I am still learning. 
11. It seems like a good idea if it is cost effective and safe. 
